Archives

Australian team hails facilities in AP MedTech

Visakhapatnam: The scope of Australia’s relationship with India has increased in line with India’s rapid economic and strategic growth, said Andrew Collister, Vice-Consul of Australian Consulate-General Chennai. A three-member team from Australia visited Visakhapatnam on Thursday and interacted with trade. The team also visited the office of AP Chambers of Commerce and Industry Federation and AP MedTech Zone.

Speaking on the occasion, Andrew Collister said that he was fascinated by the impressive work and infrastructure for producing medical devices. Collister found encouraging opportunities lying for more Australian companies by way of collaboration and technology transfer. Applauding the good initiative of making this region as Medical Manufacturing hub, Collister said the park would give a tremendous boost to the medical devices segment in the healthcare industry.

Welcoming the Andrew Collister and team, G Sambasiva Rao, president of AP Chambers of Commerce and Industry Federation, assured to extend all kinds of possible help for fostering trade relations with Australian government and explained the potential areas of investments in pharma sector, AMTZ, Tourism and IT.

Being Andhra Pradesh number one in ease of doing business as per the World Bank parameters, he promised necessary guidance would be given with the help of local authorities to Australian entrepreneurs who are willing to investment in the region.

Underscoring need for bio-medical skill certification for pan-India basis, Jitendar Sharma, CEO and MD of AP Medtech, said that convergence of technology and harmonising the skill sets by way of signing MoUs with the Australian companies would add incremental value and give AP Meditech corridor much needed boost.

With infrastructure facilities like for manufacturing, testing and certification of medical devices in the park, it would also play a big role in import substitution of medical devices, he added. With more investments lined up, large scale employment potential seems very bright in near future, Sharma claimed.

Sarah Greenbaum, Second Secretary of Political Section of Australian High Commission, said the medical devices sector is one of the most promising business segments of mutual interest to India and the Australia and it would come as no surprise that the trade relations between the two nations on this front will go deeper and stronger in the coming years.

Technology in modern Healthcare

Nigam Gupta
Salutations to all those who are working day and night for improving the most dignified profession in by making use of technologies in today’s world of competitions and added challenges. It’s passion to bring in new innovations while desire to contribute something for our coming through the then, R&D that’s sincerely going to save and secure the futures of many.
Anyway; in the modern health care environment, introduction of Technologies like Artificial Intelligence, Learning of Medical Technologies, and most importantly a new catchword ‘Internet of Medical Things’ (IoMT), got a vast amounts of clinical data that can now be gobbled up, digested and interpreted within seconds.
This is where predictive healthcare transmutes into preventive healthcare.
To begin with Andhra Pradesh MedTech Zone This is apparently the India’s reply to the World on Medical Technology, and an answer to the prayers of patients who are looking for cost effective medical treatments.
Though! For details one can log-on to their website.
However, for a quick understanding of readers, the idea of creating a manufacturing hub like AMTZ was conceived because India is import-dependent market in terms of medical devices technology to the extent of over 75 per cent. AMTZ aims to make India a self-sufficient and in fact an exporter of good quality and cost-effective medical technology. Moreover, manufacturers are not asked to go and work out in isolation. They become part of an ecosystem where they thrive and survive together. And to support them, AMTZ created scientific, commercial and social infrastructure within the zone.
Significantly, AMTZ would intend to saturate the domestic requirement and the internal markets within the country. And, what to talk of their achievements, for an example we all know that diabetes is a health concern for many. For this, Non Communicable Disease Screening is promoted in a big way.
Most of the States or hospitals are buying blood glucose strips at a high cost. What Andhra Pradesh has done is unique. In AMTZ, they are producing world’s cheapest glucometer with Bluetooth and IoT integrated in it. Because of this, they have been able to undertake screening at a much cheaper cost. It means two things – saving of money for the exchequer and screening of more people at same cost. This is a classic example of integrating industrial promotion with healthcare service delivery.
Similarly as of now, AMTZ are one the forefront of TB diagnostics then, there are only 2 companies in the world which makes linear accelerator (LINAC) for cancer care and it is one of the most complex medical equipment in the global market. Andhra Pradesh is on the verge of making a linear accelerator (LINAC) for cancer care. This will reduce the cost of cancer care. And above all, they are most likely going to produce CT Scan @ 80-90 Lakhs INR against the present import cost of near-above 3 Cr.
And as on date, there is no place in India where all the scientific facilities required for medical technology production are available in one campus itself. This is a unique feature of AMTZ that have also been shortlisted to set up incubation centre under the program of NITI Aayog. India’s first MRI, Dialysis machine will be produced in AMTZ moreover. So, in terms of policy front or infrastructure, AMTZ is ready to lead the discourse on medical technology sector in India and globally. Thus, advocating and eagerly awaiting a replica of same here in J&K too.
J&K State Healthcare Investment Policy Is of course a step near bringing the above like, areas. State Government must have brought this policy to make J&K as one of the next big medical tourism and technology hub, of India. With Health City set up, which will have ‘Corporate hospitals, Medical Colleges, Healthcare Education, Medical Equipments & Allied Industries’ there in it and then only it will attract probable investors’ players, innovators, medics or patients from world over. Not to forget, ‘Health City’ near Visakhapatnam and ‘AMTZ’ at Vizag as of now, near becoming the next Thailand, Hong Kong or Singapore. And, a likewise, zeal within the corridors of Government else enthusiasm at the seats of powers, is otherwise required to achieve the aim of making JAMMU& KASHMIR the next prominent address of healthcare envelope in the world.
Tricog: Insta ECG
An outstanding conglomerate of Bangalore based cardiologist Dr. Charit Bhograj, IIT Bombay’s Alumni and PhD from California University, Los Angeles Er. (Dr.) Zainul Charbiwala,Dr. UdayanDasgupta, an algorithms expert, and Abhinav Gujjar, who is Chief Software Architect __ found an instant solution and value proposition of ECG. Especially for the areas where presence / availabilities of full time cardiologists is less alongside heavily rushed hospitals and clinical establishments. The platform is otherwise of significant use for cardiologists too, as it helps healthcare centres in installing a cloud-based ECG machine. So at the time a doctor takes a patient’s ECG, the information is sent to their centrally located hub where a qualified expert is available 24/7. The Tricog specialist interprets it and sends back a report through an SMS as well as a message on their mobile app. This increases the speed of the diagnosis.
As per the available data “In India alone, 5 million people suffer heart attacks every year and 3 million of those don’t survive. The average time it takes to diagnose a heart attack in urban India is 360 minutes. The chances of survival with this delay are a mere 20 percent. If this delay were reduced to 90 minutes, the survival probability jumps to 80 percent. This concept of company obviously aimed to change that patient’s 80 percent chance of death to an 80 percent chance of staying alive.” Per their records above 200,000 patients have been diagnosed. And, advanced algorithms and data visualisation help our expert doctors, ensuring accuracy and speed. Yes! The team Tricog, exerting also for their next step which will be to unleash the potential for the algorithm to be used in personal health devices and wearable devices as well.
In an identical manner, SigTupleagain a Bangalore based creates AI-based solutions to automate healthcare screening. It has built intelligent screening solutions to aid diagnosis through AI-powered analysis of visual medical data. Their USP is the speed with which this data is analysed, for enabling doctors to make a quick diagnosis in life threatening situations. Then, Nirmal, A new way to check breast cancer. It is also called NIRAMAI (Non-Invasive Risk Assessment with Machine Intelligence) and yet againit’s a Bangalore-based tech start-up cofounded by Dr GeethaManjunath and team associates.
Not to forget, Robotic health-givers,machines assist Man as care giving is hard work, mind-numbing, unexciting and often emotionally draining. Correspondingly, Robotic surgery; also known as Robot-assisted surgery, it is a method of performing surgery using very small tools attached to a robotic arm. The surgeon controls and manipulates the arm from a computer console and an electronic eye in the robot arm sends back a high definition 3-D image, magnified 10 times, which the surgeon can view on the computer screen; something not possible in conventional surgery.
Recently, besides many one Dr. M R Attri, a renowned surgeon from Jammu, serving at SMHS Hospital Srinagar as Additional Professor in the PG-department of Surgery GMC-Srinagar; also recently found trying hands on Robot and well understood its role in the surgical field somewhere during an international medical education, occurrence.
All said and done, only a real performer can see opportunities within healthcare predicaments’ and medical devices sector flourishing in India. And, if things be taken in a positive note, we have ample of existing central and State Government schemes to support the zone. The only required ingredient as of now is the willingness to do something innovative among the officials and commands at seats of powers while better collective utilisation of central and state schemes to connect the collective synergies.
feedbackexcelsior@gmail.com

Bio Valley Incubation Council will reduce import dependency in healthcare sector

Visakhapatnam: The BioValley Incubation Council (BVIC) is created as part of a vibrant sector specific ecosystem being nurtured at the Andhra Pradesh Med Tech Zone (AMTZ), Visakhapatnam.

BVIC is India’s only dedicated innovation facility catering to convergence technologies relevant to India. The BioValley has created a platform to incubate emerging ideas in the fields of wearable technologies, IoMT, Nutratech, Biotech, and AI. This will integrate the healthcare sector efficiently to bring down unaddressed stress on system and individuals on out of pocket expenditure.

Innovation being the key to achieve a breakthrough in the healthcare sector, the creation of incubation avenues such as BVIC will pave way for emergence of a new healthcare sector powered by Indian innovations that would help the masses.

This would also greatly reduce the import dependency in the healthcare sector. On the sidelines of Bio Valley raising its first round of funding, Dr Jitendar Sharma, Managing Director and Chief Executive Officer of AMTZ, highlighted the long lasting need for such a facility.

Medical implants: ‘Make in India’ gets a leg-up

Several scientists from 20 premier research institutes based in the United States, the United Kingdom and Ireland have come forward to partner with the consortium formed by the Kalam Institute of Health Technology (KIHT), India’s first medical devices park AP MedTech Zone (AMTZ), Tata Steel and Indian Institute of Science-Bangalore, in developing medical implants.

KIHT executive director and AMTZ CEO Jitendar Sharma told The Hindu on Saturday on the sidelines of the second meeting of the Biomedical Implants Materials Mission that indigenous manufacturing of medical implants was being encouraged in a big way at AMTZ. The implant market in India has been estimated at ₹6,500 crore. The first phase of AMTZ has recently been completed with 22 of 80 units sanctioned going on production near the Visakhapatnam Steel Plant.

Mr. Sharma said the cost of implants, being imported from China, Korea and Germany, could be brought down almost 80% if implants were made in India. Referring to dental and orthopaedic implants, he said they had become very expensive due to the country’s dependence on imports.

To extend support

He said AMTZ and KIHT were committed to bringing the bio-material community and the entire ecosystem for undertaking research on indigenous products by institutions of merit in the country. Now AMTZ, Tata Steel and other strategic partners of the mission would extend support to units which manufacture cost-effective implants.

Focus on bio-medical implants: Prof

  • Kalam Institute of Health Technology hosts a day-long annual review on the Translational Centre of Excellence in Biomaterials for Orthopedic and Dental Applications
  • The event showcased inventions in health technology across the country

Visakhapatnam: The Kalam Institute of Health Technology (KIHT) at the AP MedTech Zone, in the city  hosted a day-long annual review meeting on the Translational Centre of Excellence in Biomaterials for Orthopedic and Dental Applications on Saturday.

This event also marked the second meeting of Bio-Medical Implants and Materials Mission (BIMM). The event was supported by the Department of Biotechnology, Government of India, KIHT, IISc Centre of Excellence and the Ceramic and Glass Industry Foundation.

The event showcased inventions in health technology across the country which is ready for industrial uptake.

The meeting discussed healthcare innovations in orthopedic and dental applications, research, manufacturing and clinical applicability in the Indian healthcare context.

Aspects of detailed intense knowledge on designs, applicability, compatibility with living systems, non-contamination attribute and antimicrobial sterilisation needs, were also put into perspective.

The Curam Centre-Ireland, Georgia Tech- USA, Made Centre-South Carolina, Wyss Institute- Harvard, Tata Steel new material centre, IIT Roorkee, PSG Institute, Coimbatore, Sree Chitra, Trivandrum, IISc, Bangalore, CIPET, Chennai and CGCRI-Kolkata along with several industrial partners participated in the meeting. The meeting discussed on biomaterials and implants through knowledge convergence.

Stakeholders from various reputed institutions like IITs, NITs, IISc, VIT, National labs, MSME manufacturers, large-scale manufacturers including Tata Steel New Materials Business, Smith and Nephew and Stryker participated in the meeting.

A host of key Medical Implant manufacturing entities also joined the event to finalise the ecosystem for academia and industry collaboration.

While delivering opening remarks. Jitendar Sharma, Managing Director, and CEO, AMTZ shared the role of AMTZ and KIHT in bringing the bio-materials community together and how the entire ecosystem can promote indigenous products researched at Indian institutions of merit.

Prof Bikramjit Basu of Materials Research Centre, Indian Institute of Science and Principal Investigator of the Translational Centre of Excellence, explained the urgent need of hour in this discipline of science. Basu is instrumental in leading the Academic Consortium of the BIMM on a mission mode.

Several Center of Excellence Mentoring Committee members and co-investigators presented their research and experience in the field of biomedical materials research.

Industry representatives presented and participated in the discussion. The meeting concluded with a session for internal discussion and recommendations by the Mentoring Committee, which is a global committee with distinguished researchers from Ireland, USA, and UK.

THINK3D OPENS $6M MEDICAL DEVICE 3D PRINTING FACILITY IN AP MEDTECH ZONE

Indian 3D printing service bureau, think3D, has opened a new 3D printing facility for medical device manufacturing. The facility is located in the AP MedTech Zone, a manufacturing park for medical equipment in the Indian state of Andhra Pradesh.

The Chief Minister of Andhra Pradesh, Nara Chandrababu Naidu inaugurated the new 3D printing center.

AP MedTech Zone manufacturing park

The AP MedTech Zone has been in development since 2016 and think3D has been an active part of this project. The park, under construction in the city of Visakhapatnam, covers an area of 270 acres and is planned to be built in two phases.

Recently, the opening of the first phase of the park was announced. In phase 1, eighty companies will take part to manufacture medical equipment and by the end of phase 2, over two hundred companies will have joined the program.

India is the fourth largest market in Asia for medical devices. However, this market is largely import-based and the country imports over 80% of medical devices.

According to the technology cluster Make in India (a supporter of the AP MedTech Zone project),

“THE MEDICAL DEVICES INDUSTRY IN INDIA IS PRESENTLY VALUED AT USD 5.2 BILLION AND CONTRIBUTES 4-5% TO THE USD 96.7 BILLION INDIAN HEALTH CARE INDUSTRY.”

It is hoped that the opening of the AP MedTech Zone and think3D’s new facility will establish India as a major producer and exporter of medical devices.

The co-founder of think3D, Raja Sekhar Upputuri, said, “Medical device manufacturing requires huge up-front investment in R&D, machinery and QC facilities … the government has decided to set-up these common facilities in partnership with private entities and offer these facilities to manufacturers within park on pay per use basis thus reducing the upfront investment from manufacturer cost drastically. 3D printing & 3D design facility is chosen as one such common facility.”

 

Statistics on the medical market in India. Image via Make in India.
Statistics on the medical market in India. Image via Make in India.

3D printing medical devices

Think3D’s new operation will provide a range of on-site 3D printing and manufacturing services, including 3D scanning, 3D printing, CNC and molding techniques.

Currently, the facility houses various 3D printing technologies, such as the HP 4200, a Multi Jet Fusion system, EOS FORMIGA P110 SLS printer, and EOS M 290 metal 3D printer. 3D printers from Stratasys and 3D Systems are also available at the center.

Prudhvi Reddy, Director at think3D, said, “This facility will be used for prototype and batch production of parts for medical devices like MRI, ECG, Ultrasound machines and so on. Once these parts are manufactured, they shall undergo various tests in the biomaterial testing lab present in the park and thereafter these parts will be assembled and send to Gamma Irradiation Facility present inside the park for sterilization. This way, a complete ecosystem for product development, manufacturing, testing is available in the facility.”

The facility will be fully operational by 1 January 2019.

The inauguration of the think3D's facility. Image via think3D
The inauguration of the think3D’s facility. Image via think3D

Nominations for 3D Printing Awards 2019 are open. Let us know about the best 3D printing application in the medical sector.

To learn more about the use of 3D printing in medicine, subscribe to our 3D printing newsletter, and join us on social media: Facebook and Twitter.

We have plenty of careers for you to choose from at our 3D Printing Jobs site.

Featured image shows think3D’s new 3D printing facility in the AP MedTech Zone park. Image via think3D

Medical devices industry must be eco-friendly: Suresh Prabhu

Visakhapatnam: Union Minister for Commerce and Industry Suresh Prabhu expressed the need for an enabling ecosystem to help evolve the industry of medical devices in India. The Minister looks forward to achieve this through Andhra Pradesh MedTech Zone (AMTZ). Suresh Prabhu inaugurated National Medical Devices Promotion Council, Centre for Medical Equipment Procurement with Global e-Market and Centre for Patents for Biomedical Equipment at AMTZ on Saturday. On the occasion, he spoke about the importance of medical devices and their support to life.

The AMTZ hosted the 4th WHO Global Forum on Medical Devices which was concluded here on Saturday. The World Health Organisation has approved registration applications of 1,049 delegates from 90 countries during the conference. The delegates including, representatives from  governments, Ministries of Health, United Nations and Inter-governmental institutions including the WHO, other UN bodies, bilateral donors including GIZ (of Germany) and USAid, researchers and academia and NGOswere present in the conference. Addressing at the valedictory, Dr.Poonam Malakondaiah, Special Chief Secretary to the AP Health department, said that the need of the hour is quality, affordability, and accessibility, and with the launch of AMTZ, she looks forward to addressing the need which has remained unaddressed in India for a long time.

Managing Director and CEO of AMTZ, Dr.Jitendar Sharma shared the insights of making AMTZ, which garnered huge applause. A 270-acre MedTech Zone phase-1 got completed in just 342 days, he said. Dr.Jitendar Sharma announced that with the comprehensive infrastructure in place, this park is world’s most equipped park ahead of the western world. Any device goes through 18 tests and procedures before it is applied in a real world and AMTZ is unique in giving all those 18 tests at the same address.
The experts discussed various key topics including diagnostics, making diagnostics accessible, Oxygen supply options and systems for low and middle income countries, pricing administration, regulation and policies, fit-for-purpose policies and laws for regulation, enabling ecosystem for manufacturing in country. During the event 10 MoUs were signed adding up to 150 million USD worth investments.

10 MoUs signed at AMTZ

Three-day conference on medical devices concludes

The three-day conference of the 4th WHO Global Forum on Medical Devices on the final day on Saturday saw signing of MoUs envisaging an investment of $150 million at the AP MedTech Zone, touted as India’s first medical devices manufacturing park.

An official of AMTZ told The Hindu that in all, 10 MoUs were signed at the conference. The investments in medical technologies would give a fillip to efforts to develop the park. This was the first time that WHO hosted the prestigious event in India.

The topics which experts discussed threadbare at the conference included free diagnostics, making diagnostics accessible, oxygen supply options and systems for low and middle income countries, pricing administration, regulation and policies, enabling ecosystem for manufacturing in country, ethical issues around device donations, non-communicable diseases and priority devices and how countries were preparing to adapt to the Essential Diagnostics List recently released by WHO at the 71st World Health Assembly.

The medical devices’ industry is a Rs. 30,000-crore industry and is highly import dependant. WHO approved registration applications of 1,049 delegates representing 90 countries. The delegates included representatives from governments, United Nations and Inter-governmental institutions like WHO, other UN bodies, bilateral donors like GIZ (of Germany) and USAID, researchers and academia and NGOs with affiliations with the WHO. The number of delegates was put at 1,200.

From WHO, Tedros Adhanom, Director-General and Soumya Swaminathan, Deputy Director-General, addressed the forum via audio-visual mode. Suzanne Hill, Head of Essential Medicine Division and Henk Bekedem, WHO representative to India, attended the forum.

Focus on quality

Speaking on the occasion, Poonam Malakondaiah, Special Chief Secretary (health), said the need of the hour was quality, affordability and accessibility, and with the launch of AMTZ, the long-awaited need to reduce cost of healthcare would be achieved.

‘Radiation risks in using medical devices grossly neglected in India’

Radiation hazards in using medical devices, such as x-ray machine, are grossly neglected in the country and most hospitals and diagnostic centres do not comply with the stipulated safety norms, according to Mohammed Amir, a researcher.

He was presenting a paper at a session on regulation of medical devices on Saturday, the concluding day, at the three-day WHO Global Forum on Medical Devices at AP Medtech Zone.

He said a study conducted in five states had shown that there was very little awareness in the general public as well as professionals in the field about radiation hazards. “No attempt is being made to keep the x-ray machines and other such devices in safe rooms and to train the staff handling them to take precautions to protect themselves as well as the patients. Such devices are being handled casually, exposing people to radiation risks,” he said.

However, he said, of late the Government has initiated some steps to sensitise the public as well as the professionals on safety norms. In 10 states, a programme on safety norms has been launched but still a lot remains to be done.

Dr V.G Somani, the Joint Drug Controller, India, spoke about the steps being taken to regulate the manufacture, import and marketing of medical devices in the country. On Jan 1, 2018, a notification had been issued under the Drugs and Cosmetics Act, 1940, covering 27 medical devices including BP monitoring equipment. Rules stipulated in the notification were harmonised with the Medical Devices Rules, 2017. Still, the process was going on and many more medical devices would be notified.

He said the standards laid down by the Bureau of Indian Standards (BIS) would have to be complied with by the manufacturers, importers and others in the field. If there are no standards by the BIS, then ISO standards would have to be followed. Some of the rules would be enforced by the Centre and some by the States. AMTZ at Visakhapatnam, the first cluster of MD units in the country, would lend support to the regulatory authorities in the country, he added.

Dulce Maria Martinez Pereira and Alexandra Lemgruber spoke about the regulatory regime for medical devices in America and Latin America.

CM N Chandrababu Naidu launches Medtech Zone phase 1, 80 firms to start units from New Year

Around 240 companies will manufacture medical equipment at the Andhra Pradesh Medtech Zone (AMTZ), generating 25,000 jobs, after its completion.

VISAKHAPATNAM: Around 240 companies will manufacture medical equipment at the Andhra Pradesh Medtech Zone (AMTZ), generating 25,000 jobs, after its completion. The first phase of the AMTZ was inaugurated by Chief Minister N Chandrababu Naidu  at Pedagantyada in Visakhapatnam  district on Thursday.

Chief Minister at AP MedTech
Zone in Visakhapatnam on
Thursday | Express

“This is a big step to reduce medical expenses for common man. There are around 800 manufacturing units in Punjab, Haryana, Maharashtra, Telangana, Karnataka and Tamil Nadu. However, 70 per cent of equipment are imported from abroad, around  $35,000 crore each year. Though the AMTZ, Vizag, will be one zone for high-tech manufacturing and testing facilities, we can also export equipment to other countries,” Naidu said.

The AMTZ, in 270 acres in two phases, will be a hub for manufacturing medical devices in the country. The  first phase has been completed at a  cost of Rs 450 crore and the second phase will be completed at a cost of Rs 110 crore.

From thermometer to CT scan machines, all medical tools will be manufactured and tested at the AMTZ. The facilities include the largest 3D printing centre, bio-material testing, X-ray tube testing, pro- typing, rapid tooling, CT Scan tube, largest gamma sterilisation plant for medical devices, R&D specialists and skill specialists. The AMTZ also has two world-class incubation facilities for innovators and start-ups in the field. Also 18 laboratories will be set up.

With good scope for manufacturing of medical equipment, by 2030 India will have chances of getting $40 billion marketing opportunities. Addressing representatives from 90 countries, Naidu urged them to invest in the AMTZ. As per the National Medical Devices Manufacturing Policy 2015, he said investors  in the AMTZ  would getpermissions through single window process.

Minister of State for Health and Family Welfare Ashwini Kumar Choubey, in his address, said that India imports 70 per cent of medical devices that it requires — 25 per cent from China and 15 per cent from the USA. He opined that the AMTZ would give improved medical facilities in rural areas.

Meanwhile, Naidu also laid foundation for Intelligent Hub (I-Hub) for Digital Pedagogies to be set up knowledge partnership of UNESCO MGIEP atop Pavuralakonda.

Medical devices manufacturing hub in Vizag

The AMTZ, spread over 270 acres, will be a hub for manufacturing medical devices in the country

Rs 450 crore spent for the first phase of Medtech Zone

Rs 110 crore to be spent for the second phase

80 companies will start their manufacturing units from the New Year

240 companies will be there in the zone after completion of 2nd phase works, generating 25,000 jobs

Healthcare gets a boost in State

AMTZ to make it available to the poor at half the cost

There is a yawning gap between the demand and supply of medical equipment.

India imports over 70 % of medical devices, including high-end equipment such as CT scan, MRI, Cath lab and Linear Accelerator (LINAC), used in the treatment of cancer.

This will soon become a thing of the past with Chief Minister N. Chandrababu Naidu inaugurating the first phase of the AP Medtech Zone (AMTZ), at Peda Gantyada here on Thursday.

Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey was present.

India’s import bill on medical devices is of the order of ₹30,000 crore a year. The indigenous production will help in cutting down the import bill by 50% and making healthcare available to the poor at about half the cost.

The AMTZ will rollout the above-mentioned high-end equipment, to be manufactured indigenously, once it becomes fully functional.

KIHT is another first

The research part would be taken up by the Kalam Institute of Health Technology (KIHT), located on the same premises.

Hundreds of prototypes, developed at IITs, IISc, universities and engineering colleges, and lying in the institutions, would be auctioned to the prospective manufacturers for manufacture and testing.

The KIHT, being set up by the Department of Biotechnology (DBT), as a Government of India Project, at AMTZ will be the first of its kind in memory of former President A.P.J. Abdul Kalam. The common scientific research facilities would be developed by the Central and State governments.

“The KIHT will complement the AMTZ, making the Medtech Park, the only of its kind in the world to have all the activities pertaining to research and manufacture of medical devices in a single place,” AMTZ CEO Jitendar Sharma told The Hindu in the past.

“We can soon graduate from a ‘glove, syringe’ country to high-end medical equipment manufacturing country,” Dr. Sharma had said.

World Health Organisation (WHO) representative in India Henk Bekedam was optimistic that India could soon become a global hub for the manufacture of medical devices. While quality and safety of the devices was of paramount importance, affordability was another key factor.

Senior Adviser on Medical Devices, WHO Headquarters, Adriana Velaquez, underlined the importance of adopting better technologies for making medical devices affordable and acceptable.

Vizag, major hub for medical devices manufacture: AP CM

Chandrababu Naidu addressed the inaugural session of the fourth WHO global forum on medical devices after dedicating the Andhra Pradesh Mdtech Zone to the nation here on Thursday.

 

Visakhapatnam: Chief Minister N. Chandrababu Naidu has said that Visakhapatnam would become a major hub for manufacture of medical devices in the country and cater to the needs of the domestic and export markets.

Addressing the inaugural session of the fourth WHO global forum on medical devices after dedicating the Andhra Pradesh Mdtech Zone to the nation here on Thursday, he noted that 80 per cent to 90 per cent of the medical devices in the country were being imported and now most of them could be manufactured at AP Medtech Zone, with exports also be done later. The zone would give a fillip to the medical devices sector in the healthcare industry, he felt.

He also said that for the first time, the WHO Global Forum on Medical Devices was being held in the country andthanked the WHO representative Henk Bekedam, for choosing Visakhapatnam and AP Medteh Zone for the meet.

Union Minister of State for Health, Ashwini Kumr Chowbey, congratualted the AP Government for achievement and said the Central Government had also a role in establishing two incubation centres in the zone.

CEO and MD of AP Medtech Jitender Sharma, said that the first phase of the park was completed in just over a year’s time. India was importing medical devices worth Rs.30,000 crore every year and the park would play a big role in import substitution, he pointed out. There were 18 high-end industrial labs in the park and 80 units including 17 startups were already functioning, he revealed.

Vizag set to emerge major hub for manufacturing medical devices: Chandrababu Naidu

Visakhapatnam is set to emerge as the major hub for manufacture of medical devices in the country, meeting the requirements of the domestic market as well as the export market, according to Chief Minister N. Chandrababu Naidu.

He was speaking at the inaugural session of the fourth WHO Global Forum on Medical Devices after dedicating the AP Medtech Zone to the nation on Thursday. He said 80-90 per cent of the medical devices in the country were being imported and most of them could be manufactured at the AP Medtech Zone and even exports could be taken up at a later stage. The park would give a tremendous boost to the medical devices segment in the healthcare industry, he added. He complimented CEO Jitendar Sharma for his hard work in completing the first phase of the park in a year’s time.

He said it was the first time the WHO Global Forum on Medical devices was being held in the country and he thanked the WHO representative, Henk Bekedam, for choosing Visakhapatnam and AP Medtech Zone for the purpose. He offered to host it the next time as well.

Ashwini Kumar Chowbey, Union Minister of State for Health, congratulated the AP Government for setting up the Medtech Zone and said the Union Government had also played its part in setting up two incubation centres in the zone. He said the NDA Government was giving a lot of importance to healthcare and it had taken up the Ayushman Bharat insurance scheme for the poorer sections.

Poonam Malakondaiah, the Principal Secretary, Health, AP Government, said all facilities had been set up in the park for manufacture, testing, and certification of medical devices in the park and from a simple thermometer to CT Scan could be manufactured there. She said the product roll-out from the park would begin soon from January.

Jitendar Sharma, the CEO and MD of AP Medtech, said that in a little over a year’s time the first phase of the park had been completed, as the Chief Minister had given all co-operation and cleared all the hurdles in the construction of the park. He said India was importing medical devices worth Rs 30,000 crores per annum and the park would play a big role in import substitution. Later, exports could also be taken up. The greatest emphasis would be on quality control, with 18 high-end industrial labs in the park. Eighty units, including 17 start-ups, had already started functioning.

GeM signed with KIHT at EduTech

Visakhapatnam: Government e-Market Place (GeM) signed a MoU, here at the second day of EduTech-2018 international conference on Friday, with Kalam Institute of Health Technology (KIHT), paving way for making KIHT the Technical Secretariat for public procurement of medical devices.  This is a boon for the healthcare system in the country, as the complex world of medical devices has always posed a challenge to the Government agencies, who are mostly dependent on the inputs of the user and industry on framing procurement policies for their organisations.

The MoU was signed between both the organisations which had an august audience of Dr. Jitendar Kumar Sharma, Executive Director, KIHT and Radha Chauhan, CEO GeM, Dr. Poonam Malakondaiah, Member of Governing Body of KIHT and Suresh Kumar, Additional CEO of GeM.

This MoU sets into motion a significant step for procurement since KIHT which has a pool of medical technology experts, could aid in providing the right content of prescribing the standards and specifications for listing in GeM portal, which would drastically cut down the procurement time and provide a reliable base of quality parameters for such procurement in a cost-effective manner.

The KIHT is a premier organisation supported by the Ministry of Science and Technology, which has been pathbreaking to support government policies undertaking in the area of medical technology. The GeM, the national portal for public procurement set up by the Department of Commerce, is an online market platform that seeks to remove entry barriers for bonafide sellers and has created a vibrant e-marketplace covering a wide range of goods and services.

The association of KIHT in public procurement for medical devices removes a huge barrier in the country’s trade in medical devices, as KIHT expertise would ensure that all healthcare agencies across all the States have a uniform set of parameters for procurement and this would bring down the cost of procurement, apart from suppressing the vested interest lobby in the sector.

Andhra Pradesh MedTech Zone lauded for making cost-effective medical devices

Visakhapatnam: Continuing its efforts to promote medical technology in the country, Andhra Pradesh MedTech Zone (AMTZ) organised a mega business conference meeting ‘MedAsia Business Forum’ in the city on Monday. The conference was held at a hotel bringing together over 200 medical device manufacturers, OEM facilitators, MSMEs, innovators, start-ups, design solutions, venture fund managers, government entities.

On the occasion, Dr Jitender Sharma, Managing Director and Chief Executive Officer of AMTZ, briefed on AMTZ since its inception. He highlighted the need for India to focus more on science for technology-oriented product development and how coming together of science and innovation with supporting infrastructure can make India a leader in technology-oriented sectors. J Krishna Kishore, CEO, Economic Development Board, while congratulating the AMTZ  highlighted the initiatives taken by the Andhra Pradesh government in forging a new AP under the able leadership of Chief Minister N Chandrababu Naidu.

Rajiv Nath, Chairman of Indian Medical Association, lauded the efforts of AMTZ in making cost-effective medical devices in the country, which is presently under the grip of MNCs who sell products at exorbitant prices. Speaking on the occasion, Veena Kohli, President ADMI, highlighted the role of diagnosis, a precursor for treatments and the gross underplaying of diagnostics by the medical fraternity.

The brand ambassador for AMTZ, Virender Sehwag roped by the AP Government, was present in the conference and offered his support to the initiatives of Andhra Pradesh, which would address the needs of many poor patients in the county. The event also saw the launch of first ever hearing test app at the event by Medi Valley, the incubation arm of AMTZ.

AMTZ signed two MoUs one with BioRx Ventures for promoting innovations, prototypes and all intellectual property in MedTech and Inkoolu Private Limited, a design solutions entity for medical technologies at AMTZ. The daylong conference concluded with a panel discussion on “Various Financing Options and Investment Attractiveness of Medical Devices Sector in India.”

AMTZ campus set to host ‘4th WHO Global Medical Device Forum’ in December

Visakhapatnam: Andhra Pradesh Medical Technology Zone (AMTZ) marks a momentous milestone in the medical device manufacturing sector with the announcement of the 4th WHO Global Medical Device Forum on its Campus in Visakhapatnam from 13th-15th December 2018.
It is for the first time in the history of WHO that this conference is being hosted in India and would embark its footprints for the development of technical excellence in the health sector. Close to 2000 delegates from 194 UN Nations including India are expected to attend.
As approved by Government of India, AMTZ would host the most esteemed global congregation on medical devices at its campus which would include plenary, panels, parallel sessions, workshops, exhibition and poster sessions. The outcome would be a compilation of the best practices and guidelines on medical devices for integration into national health plans.
WHO facilitates access to affordable and effective health technologies and also strives to combat communicable diseases like influenza and HIV and non-communicable diseases like cancer and heart disease for building a better and healthier future for people all over the world. The Forum creates the platform to discuss the achievements that have been made in the field and the enormous challenges in low and middle-income countries.
AMTZ is an enterprise under the government of Andhra Pradesh, a 270-acre Zone, dedicated to Medical Device Manufacturing with 200-250 manufacturing units, common scientific facilities, expo halls, convention centre, incubation services providing one stop solution for all manufacturers. It also hosts Kalam Institute of Health Technology (KIHT) that aims to facilitate focussed research on critical components pertaining to medical devices by supporting institutions involved with R & D, Industry, policy makers and knowledge repositories. Named after India’s 11th President Dr.APJ Abdul Kalam, KIHT has been set up with the objective to distinguish basic gaps in medical technology and propose the government to do concentrated spending on such areas and help bridge any gaps between academic research and market access.

MoU signed

AAMI has certified over 7,000 biomedical engineering professionals in over 100 countries
The Indian Biomedical Skill Consortium (IBSC) took a giant leap by entering into an MoU with the Association for the Advancement of Medical Instrumentation (AAMI) paving the way for biomedical professionals to gain recognition.

AAMI has certified over 7,000 biomedical engineering professionals in over 100 countries. The MoU was signed by Dr. Jitendar Sharma, MD & CEO, AP MedTech Zone (AMTZ), and Dr. Brad Schoener, vice-president (Innovation), AAMI, in the presence of Dr. Renu Swaroop, Secretary, Department of Biotechnology, Sunita Sanghi, Director General, National Skill Development Agency, Shyam Sunder Bang, Chairman, NABCB (Quality Council of India) and others. IBSC is an initiative of AMTZ coming up near Visakhapatnam in collaboration with the NABCB – Quality Council of India and Association of Indian Medical Devices Industry (AiMeD).

BCIL signs MoU with Andhra Pradesh MedTech Zone

Visakhapatnam: The Andhra Pradesh MedTech Zone (AMTZ) hosted first of its kind Innovator’s Pitch Event in the domain of health technologies in the presence of panelists primarily from the manufacturing community.

Under the Atal Innovation Mission, NITI Aayog recently shortlisted AMTZ as an AIC incubation centre. The event was an outreach effort to enable incubates for the AIC, registered as AIC–AMTZ Medi Valley Incubation Council (Medi Valley).

In all, 16 teams participated from eight different states at the event held at PHD Chamber of Commerce and Industry, New Delhi, on Tuesday. The panelists from the Association of Indian Medical Device Industry, Subhash Punja, Managing Director, Dr GD Agarwal, CMD, Surgiwear and Ashish Dange, CEO, Ophtechnics.

Among other panelists, Vishal Gandhi from BioRx provided the much needed financial and go to market knowhow while Biraj Swain, Fellow-ICFJ Washington DC and Contributing Editor of Newslaundry suggested societal and outreach perspectives.

Such innovation pitch judged from a manufacturer’s point of view is unprecedented in the national start-up scenario. A selected number of incubates were shortlisted for initial incubation. The remaining were also selected for pipeline of prototype development for a longer timeline in view.

As a part of the event, Dr Jitendar Sharma, CEO of AMTZ, spoke on the role such manufacturing focused incubation centre would play in the changing MedTech landscape of the country and how every single innovator could be supported in the process to promote indigenous manufacturing in this sector.

On the occasion, MoU signed between the Biotechnology Consortium India Limited represented by its Managing Director Purnima Sharma and Dr Jitendar Sharma, CEO of AMTZ

NID provides design impetus to AP Medtech Zone

AHMEDABAD: National Institute of Design (NID) and Andhra Pradesh Medtech Zone (AMTZ) jointly organized a design orientation programme at NID’s Ahmedabad campus on August 13. Based on the design promotion activity of Design Clinic scheme – an initiative of Ministry of MSME and NID – the orientation programme focused on medical devices sector and was attended by more than 150 participants including entrepreneurs, designers, academicians and government officials.

Professor Pradyumna Vyas, director of NID, focused on design intervention in the medical device sector during his interaction. “The sector is highly dominated by the import and there is a high potential for making the sector import-free by promoting better design,” he said.

Dr. Jitendra Sharma, MD and CEO of AMTZ, said that the government is supporting medical device manufacturing at Vishakhapatnam with world-class facilities.

A number of award-winning designers from the sector put forth their perspective along with case studies to stress upon factors such as product design, user interface, mobility and design enterprise.

Jitendra Singh Rajput, head of NID’s Design Clinic Scheme for MSMEs, mentioned that the design clinic has helped about 40 projects from medical sector. “such initiatives are expected to create a major impact on design among medical device sector of the country,” he said.

Two medical device cos soon to start operations at India’s first govt funded medical device park in Andhra Pradesh

The Andhra Pradesh MedTech Zone (AMTZ) – India’s first government funded medical devices manufacturing park at Visakhapatnam will soon roll out indigenous medical devices as it has inked formal agreements with two companies for which layout has been approved and construction has started.

The park which also houses four medical device testing centres with 18 different types of testing facilities under one roof has booked 28 companies out of total 45 companies in the first phase. AMTZ is spread over 270 acres and first phase is envisaged to cover 70 acres of land and the rest will be covered under subsequent phases. The company which takes up the project at AMTZ is leased the land at a rate of Rs. 1,500 per square feet.

According to an official associated with the development, “We expect one of the two companies with one of them dealing with point-of- care testing and rapid testing products to start operations by next month.”

AMTZ has also inked formal agreements with the various scientific facilities which include Centre for Electro-Magnetic Interference/ Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for Biomaterials Testing, Centre for X-ray and CT Scan Tube Manufacturing, Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling, Centre for Gamma Irradiation and AMTZ Central Warehouse.

The AMTZ with in-house high investment scientific facilities would help Indian manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Kalam Institute of Health Technology (KIHT), India’s first institute dedicated to medical technology located at AMTZ, Visakhapatnam is also working towards building a robust system for innovation in the medical devices sector in the country. It recently received 100 per cent financial support from the Department of Biotechnology (DBT).

KIHT is also working towards hosting a first of its kind congregation of innovators, investors and manufacturers for technology transfer from academia to industry for commercialization. KIHT’s proposition is further strengthened through its partnership with Association of Indian Medical Device Manufacturers (AIMED) which brings access to technical bandwidth from the industry and opportunities for deeper collaboration with the medical device industry.

The medical device park is proposed to have all such facilities in-house that are required for specialized product verticals to reduce manufacturing process costs. The park will provide modern state of art common facilities such as specialised laboratories, warehousing, testing centre, independent manufacturing units, each in a built-in ready to use area of 0.5 to 1 acre each.

A dedicated medical devices park would be of immense help in reducing import dependency, increasing export while generating wealth and employment within the country.

Indian medical device industry is worth over Rs. 60,000 crore and country’s import bill for this segment amounts to over Rs. 23,000 crore while export amounts to only over Rs. 7,000 crore. India’s import dependency on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for other devices.

AMTZ sets up centre for bio-materials testing to help cos to test products

A scientific facility – Centre for Biomaterial Testing – has been developed in country’s first medical technology manufacturing park- Andhra Pradesh Med Tech Zone (AMTZ) to help manufacturers test their products and assist them to overcome deficiencies in their products, thereby enhancing product value in the market.

The facility will help serve the purpose of sterility evaluation, histopathology evaluation, physio-chemical evaluation, accelerated aging and package validation in accordance with international standards like ISO and ASTM to to address unmet clinical needs.

Accelerated aging is an artificial procedure for establishing the lifespan or shelf life of a product in an expedited manner. Data obtained from the study is based on conditions that simulate the effects of aging on the materials.

Biomaterials are materials of natural origin or made synthetically which can be implanted to replace or repair missing tissue. There is a growing emphasis on testing services for biomaterials and biopolymers demand of which has increased as they have found increasing application within healthcare technology, such as regenerative dentistry, bone graft, tissue scaffolds, wound care, implantable devices and cosmetic surgery.

To focus on addressing some of these challenges, newer bio-materials are constantly developing as the path from laboratory bench to the point of care is rough and unpredictable with technical, regulatory and marketing hurdles.

The state-of-the-art laboratory which is primarily intended for medical device industry for physio-chemical evaluation as well as biological evaluation of samples can also serve industries like chemical, polymer and pharmaceuticals to evaluate the characteristics of materials using spectroscopic and imaging modalities like scanning electron microscopy (SEM) and transmission electron microscopy (TEM).

AMTZ has also inked formal agreements to set up scientific facilities like Centre for Electro-Magnetic Interference/ Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for X-ray and CT Scan Tube Manufacturing, Centre for 3D Designing, Printing, Rapid Prototyping & Tooling and Centre for Gamma Irradiation.

AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Centre for Biomaterial Testing ready at MedTech Zone

It can service medical device, chemical, polymer, pharma sectors
Centre for Biomaterial Testing has been developed at the Andhra Pradesh MedTech Zone, near Visakhapatnam Steel Plant, to address various unmet clinical needs and challenges with regard to newer biomaterials.

Biomaterials are materials of natural origin, or made synthetically, which can be implanted to replace or repair missing tissue.

The centre assumes significance in view of the need for testing services in healthcare technology such as regenerative dentistry, bone graft, tissue scaffolds, wound care, implantable devices, and cosmetic surgery.

The centre has facilities such as sterility, physiochemical, histopathology evaluation, accelerated ageing and package validation.

The tests are performed in accordance with international standards such as ISO and ASTM, a spokesman for the A.P. MedTech Zone has said.

The state-of-the art laboratory, which is primarily intended for medical device industry for physiochemical evaluation as well as biological evaluation of samples, can also service industries such as chemical, polymer and pharmaceuticals, to evaluate the characteristics of materials using spectroscopic and imaging modalities.

The facility will allow the manufacturers to test their products at a very low-cost price and assists them to overcome deficiencies in their products, thereby enhancing product value in the market.

AMTZ sign letter of intent with IBF for distribution of devices in South African markets

Andhra Pradesh MedTech Zone (AMTZ) – India’s first medical device park at Visakhapatnam – has signed a letter of intent with India Business Forum (IBF), South Africa for distribution of medical devices made at AMTZ for South African markets.

AMTZ is focused on building the medical technology ecosystem in India to cater to both local demand and export of Made in India products.

The BRICS manufacturing working group has also commended AMTZ model of manufacturing of medical devices. It has agreed to put up a proposal for financing scientific centre development projects in health care through New Development Bank (NDB) with two exclusive centres in each of the BRICS member countries.

NDB aims to mobilize resources for development projects in BRICS, emerging economies and developing countries.

AMTZ which is a member of the BRICS manufacturing working group from India was recently selected by World Health Organization (WHO) to setup the pre-qualification cell for In Vitro Diagnostics (IVD), which is the first of its kind in South East Asia.

Further to this, in order to drive ‘Made in India’ exports of medical technology products, AMTZ also signed an MoU with Engineering Export Promotion Council of India (EEPC). This MoU will provide support for Indian medical device manufacturers to increase export of ‘Made in India’ products to cater to global medical device demand of Rs. 30 lakh crore.

The partnership will enable manufacturers at AMTZ with access to global exhibitions and export promotion events, where Indian medical technology products can be showcased, with support from Engineering Export Promotion Council.

AMTZ partnership with EEPC would provide support in the areas of domestic regulations and technical support relating to medical devices. This partnership also paves the way for creating an export promotion body for medical devices which will ensure that Indian medical devices can compete in global markets. The AMTZ ecosystem which already offers best in class infrastructure, scientific facilities, regulatory support, preferential market access will also enable manufacturers to export globally with this partnership.

EEPC India is the premier trade and investment promotion organization in India. It is sponsored by the commerce ministry and caters to the Indian engineering sector. As an advisory body it acts as an interface between the engineering industry and the Central Government. It also serves as the reference point for the Indian engineering industry and the international business community in its efforts towards establishing India as a major engineering hub in the coming future.

New facility at Andhra Pradesh MedTech Zone

Visakhapatnam: Biomaterials are materials of natural origin or made synthetically which can be implanted to replace or repair missing tissue. There is an emphasis on testing services for biomaterials and biopolymers which has increased demand as they have found increasing application within healthcare technology, such as regenerative dentistry, bone graft, tissue scaffolds, wound care, implantable devices and cosmetic surgery.

To address various unmet clinical needs and challenging problems, newer biomaterials are constantly being developed and ideas are evolving. However, the path from the laboratory bench to the patient is rough and unpredictable with technical, regulatory and market hurdles along the way.

To focus on addressing some of these challenges, a scientific facility “Centre for Biomaterial Testing” has been developed in Andhra Pradesh MedTech Zone (AMTZ).

The highlights of Centre for Biomaterial testing facility at AMTZ includes sterility evaluation, histopathology evaluation, physiochemical evaluation, accelerated aging and package validation. The tests are performed in accordance with international standards like ISO and ASTM.

The state-of-the-art laboratory, which is primarily intended for medical device industry for physio-chemical evaluation, as well as biological evaluation of samples, can also serve industries like chemical, polymer and pharmaceuticals to evaluate the characteristics of materials using spectroscopic and imaging modalities like SEM and TEM.

This facility allows the manufacturers to test their products at a very low-cost price and assists them to overcome deficiencies in their products, thereby enhancing product value in the market.

AMTZ introduces MedTech Innovation and Rapid prototyping facility at Visakhapatnam

In order to serve medical device manufacturing of 250 manufacturing units, India’s first medical device park -Andhra Med Tech Zone (AMTZ) has set up the MedTech Innovation and Rapid prototyping facility – a common scientific facility at Visakhapatnam to promote innovation, aid customization and rapid prototype development of medical products as part of Make In India Programme.

The state of the art facility at AMTZ offers 3D designing services, 3D scanning services, 3D printing services, prototyping services and low volume manufacturing all under one roof.

The facility will allow manufacturers, start ups and innovators to design and develop the prototypes at a very affordable price and assist them to drive their innovations to market in shorter time.

3D printing is an enabling technology that encourages and drives innovation with unprecedented design freedom while being a tool-less process that reduces prohibitive costs and lead times. It is a revolutionary form of advanced manufacturing where solid objects are printed by specialised machines using digital designs as input.

The technology is being recognized for its enormous potential for in house manufacturing, mass customization, rapid innovation, reduction in carbon footprint, lead time and speed, better healthcare and interactive education. By 2020, 3D printing market is expected to grow with CAGR of 25 percent and reach USD 17 billion market globally which includes hardware, supplies and services.

AMTZ is an innovative science park spread over 270 acres dedicated for medical device manufacturing of 250 manufacturing units and is equipped with common scientific facilities, expo halls, convention centre, incubation facilities providing one stop solution for medical device manufacturers.

MedTech Innovation and Rapid prototyping facility is one of the common scientific facilities for rapid prototype development of medical products.

The facility primarily introduced for medical device development and customised implants such as replacement of hip bones or dentures made through 3D printing would bring about revolutionary changes in healthcare.

This industrial 3D manufacturing represents the future of digital manufacturing and will help secure Andhra Pradesh position at the forefront of materials development and manufacturing with plethora of opportunities to start-ups with innovative ideas.

This prototyping facility without expensive moulding tools can also serve manufacturing sector such as automobiles, aerospace, jewelery and architecture which will usher in sea-change in the state.

3D printing facility at MedTech Zone

AP MedTech Zone, medical devices manufacturing park coming up near Visakhapatnam Steel Plant offers 3D printing, designing and prototype services.

MedTech Innovation and Rapid Prototyping Facility is one of the common scientific facilities aimed at giving a big boost to ‘Make in India’ programme.

3D facility at Andhra Pradesh MedTech Zone Limited

Visakhapatnam: Andhra Pradesh MedTech Zone Limited (AMTZ), Visakhapatnam, is an innovative Science Park spread over 270 acres dedicated for medical devices manufacturing with 200-250 manufacturing units, common scientific facilities, expo halls, convention centre, incubation facilities providing one stop solution for medical device manufacturers.

The MedTech Innovation and rapid prototyping facility is one of the common scientific facilities to promote areas of innovation and aid customisation and rapid prototype development of medical products for giving a big boost to Make in India programme.

The state of the art facility at AMTZ offers 3D designing services, 3D scanning services, 3D printing services, prototyping services and low volume manufacturing all under one roof is a unique and one of its kind facility in the country.

The facility primarily intended for medical device development and customised implants such as replacement of hip bones or dentures made through 3D printing which would bring revolutionary changes in healthcare.

This prototyping facility without expensive moulding tools can serve manufacturing sector such as automobiles, aerospace, jewellery, architecture which will undergo a sea-change in the state with the facility coming up in Visakhapatnam.

This industrial 3D manufacturing represents the future of digital manufacturing and will help secure Andhra’s place in material development and manufacturing with a plethora of opportunities to start-ups with innovative ideas.

The facility allows manufacturers, start-ups and innovators to design and develop the prototypes at an affordable price and assist them to drive their innovations to market in short time.

The 3D printing is an enabling technology that encourages and drives innovation with unprecedented design freedom while being a tool-less process that reduces prohibitive costs.

It is a revolutionary form of advanced manufacturing, where solid objects are printed by specialised machines using digital designs as input. The 3D printing is being recognised for its enormous potential for in house manufacturing, mass customisation, rapid innovation, reduction in carbon footprint, lead time and speed, better healthcare and interactive education.

Visakhapatnam Being Evolved as Best Livable City

With a series of ongoing smart projects, Visakhapatnam is rising in the rank of cities that have emerged as finest in the country. The city’s projects like city surveillance, pollution monitoring, smart street, command and communications centre are meant to ensure better satisfaction level of citizens, says Pravin Kumar, Collector and District Magistrate, Visakhapatnam, in conversation with Elets News Network (ENN).

Q Andhra Pradesh is known for delivering good governance through e-Governance. How Visakhapatnam fairs with regard to delivering better citizen services?

Andhra Pradesh is the leader in e-Governance initiatives in India. e-Pragati platform is one such initiative which is unique in terms of any such global initiatives. Each activity related to governance is monitored by Real Time Governance (RTG) society and Command Control Centre (CCC) in Amaravati.

Use of the Internet of Things (IoT) in governance is to improve service delivery and transparency. Like ration or pension distribution are biometric enabled. Employees and students’ attendance is being marked on real time basis.

Real time weather forecast, groundwater level measurement etc, are helping us to monitor environmental issues on real time. Monitoring of health and nutrition activities in far off places is conducted using technology.

Parishkara Vedika 1100 Call Centre is a scheme to facilitate citizens in raising various issues before the direct notice of Chief Minister. All the services i.e. approvals of building plan, death certificates etc are today available online. These can be availed without any human interface.

Q Visakhapatnam is all set for urban transformation through Smart City Mission. What is the future course of action?

Even before smart city mission, the Government of Andhra Pradesh (GoAP) and Chief Minister’s vision was to develop urban infrastructure and use of technology at par with the best in the world. Projects like city surveillance, pollution monitoring, smart-street, command and communication centres are meant to ensure a better satisfactory experience for citizens.

Today, we are one of the cleanest and greenest cities of India. Besides, beach front developments, international convention centre, sport city projects etc. will be done at the earliest.

Visakhapatnam

 

Q What are the focus development areas in Visakhapatnam?

The focus areas include industrial growth including pharma and other industries in three different clusters of the District. Health City, Sports City and making the District the best in terms of ease of doing business are some of the priority areas.

Other focus areas include marine and aquaculture productivity. Also, resolving all kinds of land issues and completing International Convention Centre figure top in the priority chart.

There are Smart City Projects, Urban Development Projects like Master Plan Road and World Bank projects like Beach Front development, road works. Also, my priority is to improve health and education and road/telecom connect in tribal areas.

Q ‘The Jewel of the East Coast’ is set for a new identity — AP MedTech Zone and Medical Tourism Hub. How will these two initiatives help Vizag in getting highlighted as a global investment hub?

Med-tech zone will be a world class facility for the production of healthcare devices.

Q How is the District administration ensuring affordable and accessible healthcare services?

Andhra is a leader in health services. It’s duly bringing in service provider model. Almost 25 such services are being provided. NTR Vaidya Seva and ‘Health for All’ initiatives have been undertaken to achieve universal healthcare coverage goal. Infrastructure is being strengthened in seven teaching hospitals to provide best healthcare facility to the people of the State. To promote health tourism, a Health City is to be established in the heart of the city.

Andhra Pradesh MedTech Zone India’s Answer to the World on Medical Technology

AP Medtech Zone is an answer to the prayers of patients who are looking for cost effective medical treatment, says Dr Jitendar Sharma, Managing Director & CEO, Andhra Pradesh MedTech Zone (AMTZ) and Advisor (Health and Medical Technology), Government of Andhra Pradesh, in an interview to Souvik Goswami and Gopi Krishna Arora of Elets News Network (ENN).

Q Andhra Pradesh has been a leader on many fronts when it comes to healthcare spectrum. Share with us the journey of the State.

The healthcare delivery traditionally has been understood as mechanisms to provide better care. But Andhra Pradesh has combined service delivery with industry promotion. This has been the unique trajectory taken by the State. While innovative models of healthcare service delivery are being adopted, innovated and implemented the industrial promotion part of healthcare service delivery, which means fiber optics, bandwidth of internet, production of medical devices, etc, Andhra Pradesh has been on the forefront in all of these. This has made Andhra Pradesh the only State in India and perhaps one of the very few provinces in the world that has efficiently integrated industry promotion with service delivery.

Q Can you give some examples of the unique feature of integration of service delivery with industry promotion?

We all know that diabetes is a health concern for many. For this, NCD screening is promoted in a big way. Most of the States or hospitals are buying blood glucose strips at a high cost. What Andhra Pradesh has done is unique. In AMTZ, we are producing world’s cheapest glucometer with Bluetooth and IoT integrated in it.

Because of this, we have been able to undertake screening at a much cheaper cost. It means two things — saving of money for the exchequer and screening of more people at same cost. This is a classic example of integrating industrial promotion with healthcare service delivery. Similarly we are one the forefront of TB diagnostics.

Also let me share with you that, there are only 2 companies in the world which makes linear accelerator (LINAC) for cancer care and it is one of the most complex medical equipment in the global market. Andhra Pradesh is on the verge of making a linear accelerator (LINAC) for cancer care. This will reduce the cost of cancer care.

Q What has been the progress of Andhra Pradesh Medtech Zone (AMTZ)?

AMTZ is yet to celebrate its second birthday. But we are already famous globally in this short span of time. Recently AMTZ has been awarded by the American Association for Clinical Engineering – an international organisation of repute on medical technology. In the history of this organisation, no Indian organisation has been even ever nominated. But AMTZ has got recognition from them. You must be wondering on why AMTZ has been given this award. It is because AMTZ has been able to lay down a costeffective model of medical technology production and all our laboratories are almost ready. In the world, there is no place, where all the scientific facilities required for medical technology production are available in one campus itself. This is a unique feature of AMTZ.

We have been able to create a rainbow of institutions like Kalam Institute of Health Technology, WHO pre-qualification cell for In Vitro diagnostics, Directorate of Radiation safety, etc and we have also been shortlisted to set up incubation center under the program of NITI Aayog. Our first product is set to be launched on 18 August, 2018. India’s first MRI, Dialysis machine will be produced in AMTZ too. 40 percent of the area is already sold out and more than 50 companies have been roped in there. So, in terms of policy front or infrastructure, AMTZ is ready to lead the discourse on medical technology sector in India and globally.

Q What fascinated all these companies and experts to come to AMTZ?

It’s about just three things. First, the scientific infrastructure provided by the State Government which is of finest class. Second comes the preferential market access policy by the Department of Industrial Policy & Promotion (DIPP), Government of India, which legally and tangibly provides preference to an Indian manufacturer to qualify in government procurement system. Thirdly, good governance in Andhra Pradesh, which is led by none other than the Chief Minister of the State — Chandrababu Naidu, who is recognised globally for his governance. The success of AMTZ is equally the success of medical technology sector as a whole in India.

Q Andhra Pradesh has been a leader when it comes to using medical technology for providing better healthcare delivery. What is your opinion on this?

We are number one when it comes to the use of innovative technology for providing healthcare services. Andhra Pradesh is the only State in India where most of the technology incentive programmes of National Health Mission are implemented 100 percent.

Q On the other hand, Visakhapatnam is coming up as the next big medical tourism hub. Shed some light on this.

On the occasion of ‘AP Health Festival’ being jointly organised by Government of Andhra Pradesh & Elets Technomedia Pvt Ltd, we are launching an organisation called Andhra Pradesh Medical Tourism Hub (AMRIT) in Visakhapatnam. Most of the hospitals in various metro cities are facing the problem of space cramp. It is possible to send section of the patients to picturesque settings of Visakhapatnam near the beach, with wellness & Spa facility, under the close monitoring of doctors and with tie ups with hospitals, so that patients can recover in a better ambience and can stay in a relaxed mood. AMRIT is being set up with the partnership Ministry of Tourism, Ministry Health & Family Welfare and Department of  Ayush, Government of India. Also a state-of-the-art Health City is being set up which will have 40 hospitals in it and this will attract patients from world over for major surgical medical treatments. This ‘Health City’ near Visakhapatnam can be the next Thailand, Hong Kong or Singapore. Our aim is to make Visakhapatnam the next prominent address of healthcare envelope in the world.

Q Share with us your vision on AMTZ along with the overall healthcare spectrum of Andhra Pradesh.

Andhra Pradesh is the first State in India to have announced Universal Health Coverage in 2017 and doing quite well on that front. The State will become an example of one-of-its-kind through outcome- based approach, result-oriented efficiency model and evidence-based monitoring. It is going to be a model for the rest of the world to follow in healthcare. On the other hand, AMTZ comes with a great advantage of being the only zone of one of its kind, globally. It comes with lots of advantages. It’s an apple of the eye of med-tech industry in India. AP Medtech Zone is an answer to the prayers of patients who are looking for cost-effective medical treatment.

India, Cuba sign MoUs to enhance co-operation in field of Biotechnology, medicine & homoeopathy

India and Cuba on June 22, 2018 signed two Memorandum of Understandings (MoUs) in the field of biotechnology, traditional medicine and homoeopathy.

The agreements were signed following delegation-level talks between President Ram Nath Kovind and his Cuban counterpart Miguel Mario Díaz-Canel at Revolution Palace in Havana, Cuba.

The President was accompanied by a delegation including Minister of state for steel Vishnu Deo Sai and two Members of parliament.

Key Highlights

• Both the countries agreed to enhance cooperation in biotechnology, renewable energy and traditional medicine.

• The health ministries of Cuba and India signed an MOU to increase cooperation in traditional medicine and homeopathy.

• Meanwhile, envoys from the Ministry of Science and Technology of both the sides agreed on an MOU to deepen collaboration on biotechnology. In this context, a Letter of Intent was signed between BioCubaFarma, Cuba’s state company for pharmaceutical and biotechnology products, and India’s Kalam Institute of Health Technology.

• Cuba reaffirmed its support to India’s candidature for a permanent seat in the UN Security Council.

India-Cuba Relations

India shares a strong, cordial and friendly relations with Cuba. Cuba and India have historic ties which date back to 1959 when famous guerrilla fighter Ernesto Guevara visited New Delhi.

Both the countries are founding members of Non-Aligned Movement and have stood for South-South solidarity. The two countries have also collaborated very closely in United Nations and other forums.

Cuba, India vow to deepen economic ties

HAVANA, June 22 (Xinhua) — Cuban President Miguel Diaz-Canel met on Friday with his Indian counterpart, Ram Nath Kovind, who is on an official visit to the island to deepen economic and commercial ties.

Kovind, who arrived in the island on Thursday, was received by Diaz-Canel with military honors at the Palace of the Revolution before they held talks in private.

According to an official release, both leaders agreed to continue developing “solidarity and friendly relations” and vowed to boost cooperation for the well-being of their nations.

Diaz-Canel and Kovind expressed particular interest in boosting economic cooperation and investments as well as collaboration in science and technology and renewable energy, according to the release.

Kovind and Diaz-Canel also witnessed the signing of three new cooperation agreements in the areas of biotechnology and healthcare.

At the ceremony, the health ministries of Cuba and India inked a memorandum of understanding (MOU) to increase cooperation in traditional medicine and homeopathy.

Meanwhile, envoys from the ministries of science and technology agreed on an MOU to deepen collaboration on biotechnology.

In this context, a letter of intent was signed between BioCubaFarma, the island’s state company for pharmaceutical and biotechnology products, with India’s Kalam Institute of Health Technology.

Earlier, Kovind paid tribute to the island’s national hero, Jose Marti, by laying a flower wreath at Havana’s Revolution Square. He also visited Cuba’s main biotechnology research center to learn about innovative drugs to fight lung and skin cancer as well as foot ulcers caused by diabetes.

Cuba and India have historic ties which date back to 1959 when famous guerrilla fighter Ernesto ‘Che’ Guevara visited New Delhi. Along with Cuba, India was also a founding member of the Non-Aligned Movement.

Four-day health festival gets under way

It showcases ideas, innovations of participants from acorss the country

A four-day health festival to showcase ideas and innovations got off to a glittering start here on Monday.

The first day saw participants from across the country. The festival is being organised by the State government, AP MedTech Zone and Elects Techomedia Pvt. Ltd.

The aim of the event is to improve the health status and quality of life of the people by focusing on health issues by reducing disease burden, creating an enabling environment, influencing direct and indirect health determinants such as nutrition, water, sanitation and other factors like education and employment.

Among others, Special Chief Secretary, Health, Medical and Family Welfare Poonam Malakondaiah, Advisor (Health) Jitendar Sharma and Collector Pravin Kumar were present.

On the inaugural day, hackathon and datathon were organised. The winners will be given prizes.

AP Health Festival begins with Hackathon and Datathon competition

Ushering a unique blend of opportunity for young professionals to innovate and improve healthcare services, the first day of the Andhra Pradesh Health Festival has begun in Visakhapatnam.

The first day of the festival registered the participation of contestant from across the country, who will continue to work on the projects till 20 June, being a part of the Hackathon and Datathon completion.

The festival will continue from 18-21 June and has been organised by Medical, Health and Family welfare department- Government of Andhra Pradesh, Andhra Pradesh MedTech Zone and Elets Technomedia Pvt Ltd.

The motive behind this initiative is to improve the health status and quality of life of the people in Andhra Pradesh, by focussing on health issues with the objective of reducing disease burden, creating an enabling environment, influencing direct and indirect health determinants such as nutrition, water, sanitation and other factors like education and employment in the state.

The first day of the festival unveiled in the presence of Dr Poonam Malakondaiah, Special Chief Secretary, Health Medical & Family Welfare Department, Government of Andhra Pradesh, Dr Jintendar Sharma, Advisor (Health), Government of Andhra Pradesh, Managing Director and Chief Executive Officer, Andhra Pradesh MedTech Zone, Pravin Kumar, Collector and District Magistrate, Visakhapatnam and several other esteemed dignitaries.

Dr Malakondaiah welcomed all the participants to the festival, commencing in Visakhapatnam. She said, “In Andhra Pradesh, technology is being used in the best possible ways to improve healthcare services, especially for those who cannot afford it. Technology is the helping us in making health, affordable and accessible to all.”

“A series of programmes have been launched in the state. This is a state with a strong technology background. Here, technology is used to leverage the level of healthcare. We are also using Information and Technology to do analytics and predict diseases for ensuring prevention in future,” she added.

Explaining more about this festival and the exciting opportunities associated with it, Dr Jintendar Sharma, Advisor (Health), Government of Andhra Pradesh, Managing Director and Chief Executive Officer, Andhra Pradesh MedTech Zone, said , “We are set to offer you three days packed with activities to generate best of the ideas. This is for the first time that a state government is trying to utilise the data mine to gather knowledge for ensuring better solutions to the humanity.I believe knowledge resides on the other side of this table, it is with you.”

Boosting the level of excitement and enthusiasm among the participants, he added, “Today, on the first day of the festival we have two parallel tracks – Hackathon and Datathon. The best ideas would get cash prizes at the end of three days. I request you to give your heart and soul to this opportunity and create the best of the ideas for the public interest. We welcome you all to the medical capital city of India-Visakhapatnam.”

While Andhra Pradesh as a state is taking several positive steps for improving healthcare services in the state, Visakhapatnam, in particular, is contributing a whole new dimension to this cause.

Pravin Kumar, Collector and District Magistrate, Visakhapatnam said, “Andhra Pradesh as a state emphasises on a lot of services, such as improving the level of education for all, affordable services etc. We are trying our level best to make this state a sustainable society. This event, in particular, will help us in getting several bright ideas, implementation of which will lead to a better society. Visakhapatnam is the third fastest growing city in India. I hope you all contribute to the betterment of the society.”

KIHT signs research agreement with JBI

KIHT would focus on medical devices and diagnostic and associate with other JBI centres in this domain of research.

The Kalam Institute of Health Technology (KIHT), a Department of Biotechnology funded institute in the domain of medical technology policy, has recently signed an agreement with Joanna Briggs Institute (JBI), University of Adelaide, Australia.

KIHT would focus on medical devices and diagnostic and associate with other JBI centres in this domain of research. All the studies done in this space would be submitted to JBI and KIHT would like to involve in supporting and leading JBI in medical devices and diagnostic space globally.

AP MedTech Zone (AMTZ) will now host the JBI along with cluster of 250 manufacturing units for common facilities such as electro-magnetic interference testing, biomaterials testing, gamma irradiation, rapid prototyping centre, Indian Biomedical Skill Consortium, WHO pre-qualified cell, Directorate of Radiation and Medical Devices Promotion Council.

AMTZ, now under construction in an area of 270 acres at Nadupuru in Pedagantyada mandal, is expected to roll out the first device manufactured in the zone under ‘Make in India’ initiative sometime in October. Common scientific facilities, biomaterial testing lab, 3D design, prototyping, rapid tooling facility, gamma irradiation, X-ray/CT scan tube manufacturing and other facilities will come up at the zone.

KIHT ties up with Australian institute for research

AP MedTech Zone is expected to roll out first device under ‘Make in India’ initiative in October

Kalam Institute of Health Technology (KIHT), promoted by the Department of Biotechnology, Government of India, to facilitate focussed research on critical components pertaining to medical devices at the AP MedTech Zone (AMTZ), India’s largest medical devices manufacturing park near here, will collaborate with Joanna Briggs Institute (JBI), University of Adelaide, as an affiliated group.

AMTZ, now under construction in an area of 270 acres at Nadupuru in Pedagantyada mandal near here, is expected to roll out the first device manufactured in the zone under ‘Make in India’ initiative sometime in October.

Common scientific facilities, biomaterial testing lab, 3D design, prototyping, rapid tooling facility, gamma irradiation, X-ray/CT scan tube manufacturing and other facilities will come up at the zone.

One-stop solution

The zone, an ultra-modern medical equipment manufacturing and testing park, is expected to provide one-stop solution, reduce cost of production by 40% and simplify end-to-end operations and enable achieving import dependency for medical devices and components.

The first phase is at an advance stage of construction at a cost of ₹350 crore to ₹400 crore. It has been decided to spend about ₹1,000 crore on various facilities by the time it is ready for full-fledged operations.

Joanna Briggs Collaboration (JBC) is a key body that contributes to the global success of the JBI with respect to scholarly outputs and geographic footprint. The JBC has grown exponentially over past 20 years. It now incorporates over 80 entities internationally across five regions.

KIHT will focus on medical devices and diagnostic and associate with other JBI centres in the domain of research. All the studies made in this space will be submitted to the JBI and the KIHT is expected to involve in supporting and leading JBI in medical devices and diagnostic space globally. Official sources told The Hindu that AMTZ will now host the JBI along with cluster of 250 manufacturing units for common facilities such as electro-magnetic interference testing, biomaterials testing, gamma irradiation, rapid prototyping centre, Indian Biomedical Skill Consortium, WHO pre-qualified cell, Directorate of Radiation and Medical Devices Promotion Council.

KIHT ties up with JBI to boost research in medical devices & diagnostics

Kalam Institute of Health Technology (KIHT) a regional hub for conducting health technology assessment recognized by department of health research under the union health ministry has got another feather in cap by getting associated with Joanna Briggs Institute (JBI), University of Adelaide as the affiliated group.

KIHT would focus on medical devices and diagnostic and associate with other JBI centres in this domain of research. All the studies done in this space would be submitted to JBI and KIHT would like to involve in supporting and leading JBI in medical devices and diagnostic space globally.

Andhra Pradesh MedTech Zone Ltd (AMTZ), India’s first government funded medical devices manufacturing park would now be also hosting JBI along with cluster of 250 manufacturing units includes common scientific facilities like electro-magnetic interference testing, biomaterials testing, gamma irradiation, rapid prototyping centre, etc., Indian biomedical skill consortium, World Health Organization (WHO) pre-qualification cell, directorate of radiation and medical devices promotion council.

These institutes would contribute in developing standard and quality in Indian medical technology industry and services and bring Indian market at par with global market.

The Joanna Briggs Collaboration (JBC) is a key body that contributes to the global success of the Joanna Briggs Institute, with respect to scholarly outputs and geographic footprint. The JBC has grown exponentially over the course of the 20-year history of the Institute and now incorporates more than 80 entities internationally across five regions of the world.

WHO has selected AMTZ to host its pre-qualification cell for in vitro diagnostics (IVD) which is a first of its kind in South East Asia.

This pre-qualification cell, which will provide guidance to Indian manufacturers on the WHO pre-qualification of IVDs programme and will also enable manufacturers to match global quality standards. It will also help manufacturers to participate in UN procurement process for IVD devices enabling export.

WHO will provide the required training to the support cell staff to guide the manufacturers about WHO pre-qualification expectations while AMTZ will handle day to day operations. AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Australian Institute makes home in Vizag

Kalam Institute of Health Technology (KIHT) a regional hub for conducting Health Technology Assessment recognised by Department of Health Research, Ministry of Health and Family Welfare, has got another feather in cap by getting associated with Joanna Briggs Institute, University of Adelaide as the affiliated group.

The Joanna Briggs Collaboration (JBC) is a key body that contributes to the global success of the Joanna Briggs Institute (JBI), with respect to scholarly outputs and geographic footprint. The JBC has grown exponentially over the course of the 20-year history of the Institute and now incorporates more than 80 entities internationally across five regions of the world.

KIHT would focus on medical devices and diagnostic and associate with other JBI centres in this domain of research. All the studies done in this space would be submitted to JBI and KIHT would like to involve in supporting and leading JBI in medical devices and diagnostic space globally.

AMTZ would now be also hosting Joanna Briggs Institute along with cluster of 250 manufacturing units includes common scientific facilities like Electro-Magnetic Interference Testing, Biomaterials Testing, Gamma Irradiation, Rapid Prototyping Centre, etc., Indian Biomedical Skill Consortium, WHO Pre-qualification cell, Directorate of Radiation and Medical Devices Promotion Council. These institutes would contribute in developing standard and quality in Indian medical technology industry and servicesand bring Indian market at par with global market.

AP Medtech Zone wins ACCE-2018 global award

Visakhapatnam: AP Medtech zone won American College of Clinical Engineering(ACCE)-2018 international award. In collaboration with the Healthcare Technology Foundation, the ACCE conferred the “International Organization Award” on AP Medtech Zone (AMTZ) during the 28th ACCE annual meeting held on June 2 at California. Managing Director and Chief Executive Officer of AMTZ Dr Jitendra Sharma received the award.

The ACCE is an internationally recognised professional society for clinical engineers with membership across the globe. ACCE was founded in 1990 and established with a special focus on promoting the profession of clinical engineering in the international arena. ACCE–HTF International Organization Award is given to an organisation outside the United States and Canada that has demonstrated significant improvements in Clinical Engineering and AP Med Tech Zone is the first Indian organisation to have been nominated ever for the award.

AMTZ has been making rapid progress by creating an innovative industrial park for manufacturing of medical devices with a holistic ecosystem for promotion of the medical technology products in India. The initiative of AMTZ is applauded by the industry in India and medical technology experts all over the world.

In a first, AP Med Tech Park gets International Engineering Award

Andhra Pradesh Med-Tech Park has created a record by winning the 2018- ACCE international award. American College of Clinical Engineering in collaboration with the Healthcare Technology Foundation (ACCE / HTF) conferred the “International Organisation Award” to Andhra Pradesh MedTech Zone (AMTZ) during the 28th ACCE annual meeting held on 2 June, 2018 in California.

The award was received by Dr Jitendra Sharma, MD & CEO AMTZ, who is a renowned international figure in the field of medical technology and healthcare.

Founded in 1990, the ACCE is an internationally recognised professional society for clinical engineers with memberships across the globe. It was established with a special focus on promoting the profession of clinical engineering in the international arena. ACCE – HTF International Organisation award is given to an organisation outside the United States and Canada that has demonstrated significant improvements in Clinical Engineering.

This award is sponsored by the Healthcare Technology Foundation on behalf of ACCE. AP Med Tech Zone is the first Indian organisation to have been nominated ever for this award.

India is import dependent to the extent of 80 per cent amounting to Rs. 25,000 crore per annum in medical technology sector.

AMTZ has been making rapid progress by creating an innovative industrial park for manufacturing of medical devices with a holistic ecosystem for promotion of the medical technology products in India.

The initiative of AMTZ is applauded by the industry in India and medical technology experts all over the world.

The AMTZ value proposition includes R&D support, avenues for technology transfer, world class infrastructure, regulatory support and access to local as well as global demand.

The zone provides manufacturers with capital intensive state-of-art scientific facilities at a very low cost thus reducing the cost of manufacturing which will help in reducing the overall cost of healthcare delivery not just in India but globally.

The recognition by ACCE has added another feather to the cap of AMTZ which in a short span of two years has paved the path of creating various institutions like Kalam Institute of Health Technology (supported by DBT, Govt, of India), WHO Pre-qualification center, Directorate of Radiation Safety (under AERB, Govt. of India), Indian Biomedical Skill Consortium (in partnership with Quality Council of India), and Medi Valley Incubation Council (under Atal Innovation Mission, NITI Aayog).

ACCE award for AMTZ

AP Med Tech Park has won 2018 ACCE (American College of Clinical Engineering) international award.

ACCE in collaboration with the Healthcare Technology Foundation conferred the ‘international organisation award’ to AP MedTech Zone (AMTZ) during the ACCE annual meeting held in California on Saturday. The zone is developing a medical devices manufacturing park near Steel Plant. ACCE is an internationally recognised professional society for clinical engineers. India is import dependent to the extent of 80% amounting to Rs. 25,000 crore per annum in medical technology sector.

Commerce Min approves 15 projects for export infrastructure under TIES

The approved projects include setting up of an integrated cargo terminal at Imphal international airport; establishment of trade promotion centre in Bhopal; solid waste management system at Noida SEZ; and construction of office cum laboratory complex of export inspection agency at Vishakhapatnam.

As many as 16 projects, including setting up of a cold chain in Madhya Pradesh, were approved under by a commerce ministry scheme to develop infrastructure for promoting exports, a senior official said. Last year, the commerce ministry launched the Trade Infrastructure for Export Scheme (TIES) to create appropriate infrastructure for development and growth of exports through engagement of central or state agencies.

Of the total scheme outlay of Rs 600 crore, Rs 80 crore was provided in 2017-18 and the same amount will be provided during the current fiscal also, the ministry official said.

The scheme has been launched for three years to 2020.

The approved projects include setting up of an integrated cargo terminal at Imphal international airport; establishment of trade promotion centre in Bhopal; solid waste management system at Noida SEZ; and construction of office cum laboratory complex of export inspection agency at Vishakhapatnam.

The implementing agencies of these projects include Karnataka Fisheries Development Corporation Ltd; Visvesvaraya Trade Promotion Centre, Bengaluru; Cochin SEZ; Airport Authority of India, Coffee Board, Exports Inspection Council and Andhra Pradesh Med Tech Zone (AMTZ).

Unlike Assistance to States for Development of Export Infrastructure and Allied Activities (ASIDE) Scheme, which was funded by the Centre, the cost of projects under TIES are equally shared between the Centre and the states.

The central and state agencies, including Export Promotion Councils, Commodities Boards, SEZ authorities and apex trade bodies are eligible for financial support under the scheme.

The Central government funding will be in the form of grant-in-aid, normally not more than the equity being put in by the implementing agency or 50 per cent of the total equity in the project.

The proposals of the implementing agencies for funding is being considered by an empowered committee, chaired by the commerce secretary.

The scheme helps involve states in promoting export activities in the country. The commerce ministry is taking several steps to promote the country’s exports including improving export related infrastructure.

In 2017-18, exports recorded a growth of about 10 per cent to USD 303 billion. Higher growth in outbound shipments helps create employment opportunities, earn foreign exchange and boost economic activities.

Kalam Institute – AMTZ bring national medical technology review to Vizag

The Principal Scientific Advisor to the Government of India, Prof K Vijay Raghavan on Monday visited Kalam Institute at Vizag to take stock of the Government funded projects in health technology.

Representatives of 16 national and regional Institutions including IITs, CSIR laboratories, Department of Science and Technology Institutions were present at the meeting.

All bottlenecks related with the completion of such projects like trade barriers, import support of raw materials, testing and certification, pre-compliance, prototyping, market validation, expert opinion on specificity were discussed in details.

Kalam Institute of Health Technology and Andhra Pradesh Med Tech Zone were given the role to carry forward the support to these high-profile institutions.

All innovations across various technology readiness levels were suggested to be technology transfer through the unique e-auction platform hosted by KIHT.

Prof Vijay Raghavan appreciated the speed and focus with which Andhra Pradesh Med Tech Zone and Kalam Institute are facilitating the medical technology sector in India.

He applauded Kalam Institute’s efforts to roll out key initiatives. Many eminent personalities including Dr Jitendar Sharma, Executive Director of Kalam Institute, the scientists from AMTZ and Kalam Institute and Directors of several notable institutes across the country were present on this occasion.

Novel IPT Academy launched

Visakhapatnam: Novel IPR Academy and Novel IPR Magazine were launched here on Friday. Inaugurating the academy, Dr Jitendar Kumar Sharma, Managing Director and CEO of Andhra Pradesh MedTech Zone (AMTZ) emphasised various important aspects of IPR can render.

Managing Director of the Academy Hima Bindu A said that the academy focuses on promotion of Intellectual Property Rights Education and offers a collaborative platform connecting research, industry and investors.

The academy offers a wide range of Intellectual Property Rights courses to all the stakeholders. It offers courses designed exclusively for students, IP career seekers, researchers, entrepreneurs and industry segments tailored to their needs, she added.

Anil Neerukonda Institute of Technology and Sciences (ANITS) signed MoU with the academy in establishing the IPR Cell on its premises.The Memorandum of Understandign was exchanged between Kalam Institute of Health Technology (KIHT) and Novel Patent Services for providing the entire spectra of IPR support services at the Andhra Pradesh Med Tech Zone.

IPRs important to encourage, nurture, protect and sustain innovation: Experts

New Delhi, Apr 27 (KNN) In order to encourage, nurture, protect and sustain innovation in all the sectors, Intellectual property rights (IPR) and patenting is crucial for India’s growth, said Jitender Kumar Sharma, the Managing Director and CEO of Andhra Pradesh Med Tech Zone.

Invited as a Chief Guest on World IP day commemorating the establishment of IPR academy by a local company, Novel Patent Services Pvt Ltd, he said that the IPR should be protected in all the sectors of economy, especially the medical fields.

But in some exceptional cases, government does have the right to relax IPR rules in order to make certain essential drugs available in the economy such as the one for treating breast cancer in women at cheaper rates, he added.

Kumar said that the AP Med Tech Park is coming up in Visakhapatnam that will provide medical equipments at much cheaper rates, at roughly around 30 percent of the global costs.

These processes and products will have to be protected through IPR, he added.

During the event, a memorandum of understanding was signed between the Kalam Institute of Health Technology, Vizag, and the Novel IPR Academy on the occasion.

Also, a Novel IPR magazine was released during the event.

On explaining the objectives of the academy, Himabindu Atti, the Managing Director of Novel Patent Services, said that the role of the academy is to create and promote awareness about IPR in engineering colleges, MSMEs, start-ups and other sections.

Aiming to build IP culture and eco-system in the State, he said that we will offer licensing and commercialization services and bring IPR within the reach of everyone.

Bijay Kumar Sahu, Deputy Manager of the National Research Development Corporation (NRDC), said that the innovation should be adaptable, accessible and affordable for which IPR is crucial.

Ravi Eswarapu, president of the AP IT Association, spoke on the importance of IPR for start-ups and KRK Prasad, the Director of the MSME Institute, highlighted the need for MSMEs to adapt to the IPR regime.

Aditya Venkateswara NC, a patent examiner of the Indian Patent Office, spoke about the aspects governing patent grant and Muralikrishna, Director and founder of Novel Patent Services, said efforts would be made to set up IPR cells in all engineering colleges in the State. (KNN/YV)

Vizag-Chandigarh innovation corridor launched

In an effort to promote manufacturing of medical devices, Andhra Pradesh MedTech Zone (AMTZ) and the Chandigarh Region Innovation and Knowledge Cluster (CRIKC) have joined hands.

With this motive, the Vizag-Chandigarh innovation corridor was launched on Monday at Visakhapatnam and Chandigarh. The virtual corridor was started in a gala event in the presence of many eminent dignitaries.

The event was jointly organised by the Department of Science and Technology (DST)- Centre for Policy Research at the Panjab University, Royal Academy of Engineering, UK, NITI Aayog and AMTZ.

This virtual corridor was launched by Professor Vinod K Paul, Member NITI Aayog, in the presence of Andrew Ayre, British Deputy High Commissioner, Chandigarh, Prof Sir William Wakeham, Royal Academy of Engineering, UK, Arun K Grover, Vice-Chancellor, Panjab University, Professor Rupinder Tewari, Punjab University, Mr. Anil Jauhri, CEO, QCI – NABCB, and Scientist from reputed organisations like SCTIMST, CMC Vellore, NIB New Delhi, CRIKC institutions and Medical Device manufactures.

Speaking on this occasion, Dr Jitendar Sharma, a leading medical technology expert in the country, highlighted the need of collaboration between research institutions and manufacturing industry. This virtual corridor will benefit both industries and research institutions.

The industries can use the facilities like pre-clinical studies at research institutions while the research institutions get benefit from AMTZ by using the common scientific facilities for manufacturing combine with expertise from Kalam Institute of Health Technology (KIHT), the think tank for Research and development in MedTech, which can contribute by health technology policy.

This unique association of the two scientific hubs would pave way for future endeavours in integrative problem solving in MedTech science.

Prof Paul highlighted the relevancy of encouraging health-tech innovations and underlined the need for indigenous manufacturing of biomedical devices so that our dependency on import can be addressed. He stated that the country needs to invest heavily in allied research.

AMTZ is cluster of 250 manufacturing units which spread over 270 acres which includes common scientific facilities like Electro-Magnetic Interference Testing, Biomaterials Testing, Gamma Irradiation, Rapid Prototyping Centre, etc., In this campus the other facilitating institutions like Incubation Center, Indian Biomedical Skill Consortium, WHO Pre-qualification cell, Directorate of Radiation and Medical Devices Promotion Council.

In CRIKC cluster institutions include Punjab University, IISER Mohali, NITTR Chandigarh, C-DAC Mohali, IMTECH, CSIO, CIAB, NABI, SAE, TRRL and other CSIR and DRDO laboratories.

Country needs to invest in research, says expert

Tribune News Service

Chandigarh, April 16

The need of the hour is to strengthen the primary healthcare and to develop a system in this regard for the country.
This was stated by Prof Vinod K Paul, Member NITI Aayog, New Delhi, during the India-UK Industry-Academia Symposium which was inaugurated at the CIL Seminar Hall, Panjab University (PU), on Monday.
The event was organised by the Department of Science and Technology (DST)-Centre for Policy Research at the PU, Royal Academy of Engineering, UK, and the Ministry of Commerce and Industry, New Delhi.
He discussed a few initiatives, such as the National Health Protection Scheme, which had been kick started in India for bringing about a change. Encouraging innovations, he pushed the need for indigenous manufacturing of biomedical devices so that the country did not need to import. He stated the country needed to invest highly in research.
Andrew Ayre, British Deputy High Commissioner, Chandigarh, acknowledged the efforts of the organisers and stressed on the fact that partnerships had the ability to solve societal issues globally.
Prof Sir William Wakeham, Royal Academy of Engineering, UK, emphasised on the fact that the industry personnel should take active part in teaching modules of the academia.
Arun K Grover, Vice-Chancellor, PU, talked about the need for reforms and introduced the participants to a ‘systems thinking’ approach towards the research and innovation policy and collaborative industry-academia (I-A) researchfunding mechanisms.
Virtual corridor

The highlight of the event was the launch of the ‘South-East to North-West Virtual Corridor’ between Andhra Pradesh Medtech Zone Limited (AMTZ), Vishakapatnam, and the Chandigarh Region Innovation and Knowledge Cluster (CRIKC) for the manufacturing of medical devices.

AMTZ empanels Elets Technomedia as official ‘Knowledge Partner’

Published By: Elets-eHealth

Elets Technomedia has been empanelled as official knowledge partner by Andhra Pradesh MedTech Zone (AMTZ), an enterprise dedicated for medical device manufacturing.

An official empanelment memorandum of understanding (MoU) was signed on the sidelines of three-day partnership summit of Confederation of Indian Industry (CII), held from Feb 24-26. A total of 25 MoUs worth Rs 5,090 crore were also signed at the summit.

“Elets Technomedia Pvt. Ltd. has been empanelled as knowledge partner. You may now render ‘consultation/knowledge/technical services’ to manufacturers and scientific service providers in the domain of your service,” AMTZ said in a statement released last Friday.

In his first reaction to Elets Technomedia getting empanelled as a ‘Knowledge Partner’ by AMTZ, Dr Ravi Gupta, Editor-in-Chief and CEO, Elets Technomedia Pvt Ltd which has been organising Knowledge Conferences across India and world for over one-and-a-half decades, said: “It is indeed a matter of honour and pride.”

“It feels good to see when our team’s years long efforts and dedication to the cause of taking government intiatives to the masses and highlighting related vision and challenges are appreciated this way. It will boost our spirit of contributing to the big transformation being effected in the lives of people and govenment administration through ICT and innovations,” Dr Gupta added.

Many national and international dignitaries including Vice-President Venkaiah Naidu  Union Industry and Commerce Minister Suresh Prabhu, Andhra Pradesh Chief Minister Chief Minister N Chandrababu Naidu, and senior bureaucrats  were present on the occasion. The partnership summit aimed to bring investment, foster innovations and to bring all stakeholders on a platform to facilitate policy dialogue.

Earlier, to strengthen the existing healthcare facilities in the State, Andhra Pradesh MedTech Zone (AMTZ) announced many measures including launching of 3D printing facility for fitting implants and affordable glucometers for every household.

The announcement was made by Dr Jitender Sharma, CEO, AMTZ while speaking during the summit in Visakhapatnam on Sunday. He further said that AMTZ will also manufacture CT scan machines within a year, the first in the country to do so.

“There is not a single manufacturer of CT scan machines in India but now a 16-slide machine will come up in Vizag MedTech Zone. The high-end facility at AMTZ would include an antenna of 40 gigahertz capacity. There is also the requirement for more sophisticated and precise devices such as implants,” Sharma while speaking at ‘Medical Equipment’ session said.

MedTech Zone signs 25 MoUs worth Rs 5,090 cr

TNN | Feb 26, 2018, 02:14 IST

Visakhapatnam: Andhra MedTech Zone (AMTZ) will soon have a 3D printing facility for fitting implants and affordable glucometers for every household and will also be the first hub in the country to manufacture CT scan machines within a year, said AMTZ CEO Jitender Sharma at the ‘Medical Equipment’ session held during the CIIPartnership summit in the city on Sunday.
At the summit, a total of 25 MoUs worth Rs 5,090 crore with an employment opportunity of 4,750 jobs pertaining to the health sector were signed.

Addressing the session, state health secretary Poonam Malakondaiah said Andhra Pradesh would soon come up with an e-health record digital locker for all citizens and expressed confidence that AP’s Ayushman Bhav health insurance programme would be replicated by all other states in the future.

 Jitender Sharma said reduction of basic customs duty on medical devices that enables import of spare parts at a cheaper cost, non-requirement of FDI approval and encouraging market access policy of the government have given a boost to medical device manufacturers. At AMTZ, 18 high-end labs and 200 factories are coming up including a factory that would produce affordable glucometers.
 Dr Yogesh Patil, associated with the manufacture of low-cost Bluetooth-enabled glucometers, said, “The cost of diagnosing diabetes will soon come down from Rs 1,500-Rs 2,000 to Rs 300 to Rs 400 and glucometer strips will also become very cheap.”

Thrust was placed on manufacturing diagnostic devices and radiology equipment. “There is not a single manufacturer of CT scan machines in India but now a 16-slide machine will come up in Vizag MedTech Zone. The high-end facility at AMTZ would include an antenna of 40 gigahertz capacity. There is also the requirement for more sophisticated and precise devices such as implants,” said Sharma.

Medical equipment and devices sector in State gets a boost

Published By : The Hindu

25 MoUs with proposed investment of ₹8,000 crore signed

With an aim to boost the medical equipment and devices sector, the State government has signed 25 MoUs with a proposed investment of ₹8,000 crore with medical equipment manufacturing units on the second day of CII Partnership Summit here on Sunday. The projects will create 17,000 jobs, including direct employment to 5,000 persons.

Poonam Malakondaiah, principal secretary of Health, Medical and Family Welfare Department, said 25 MoUs were signed for manufacturing medical equipment with an investment of ₹8,000 crore at AP MedTech Zone (AMTZ) being developed near Visakhapatnam. On the sidelines of CII Partnership Summit here, she told The Hindu that the zone would be operational in phases from October. She said they had also signed MoU for cooperation with Central Scientific Instruments Organisation (CSIO) and Health Sector Skill Council of India, both Government of India organisations.

Confirmed investments

Executive Director of Kalam Institute of Health Technology (KIHT, Department of Biotechnology, and Government of India Project) Jitendar Sharma said that all the 25 MoUs were confirmed investments and not just expression of interest.

The panellists in the session on ‘Medical Equipment and Devices -Make in India- Scope in Andhra Pradesh’ said that in spite of having a market size of over ₹20,000 crore, India is currently importing over 75% of the medical equipment.

Ms. Malakondaiah said AMTZ would come up in around 270 acres of land near Nadupuru in Visakhapatnam and would be India’s first medical device manufacturing unit with eight state-of-the-art facilities and over 100 medical equipment and devices units.

QCI, AMTZ and AiMeD form Indian Bio-Medical Skill Consortium to certify capacity of Indian biomedical engineers

Published By: Pharmabiz

The Association of Indian Manufacturers of Medical Devices (AIMED) has teamed up with the Andhra Pradesh MedTech Zone (AMTZ) and Quality Council of India (QCI) to form the Indian Bio-medical Skill Consortium (IBSC).

The development of biomedical skill sector in India received a major boost and the objective of the initiative is to understand and analyse the methodology of existing certification/licencing for clinical engineers or biomedical equipment technicians by institute / association in various countries and prepare a module to benefit Indian biomedical engineering professionals.

The proposed Skill Cell will be hub for both national and international BME students and engineers to learn and gain in-depth knowledge on all medical devices, calibration and relevant areas. IBSC will give recognition to Indian biomedical engineers based on their years of experience, education and competency levels. This will benefit to approximately two lakh biomedical engineers in India and 6,500 or more fresh graduates annually. International candidates are also eligible to take this exam.

IBSC proposes to develop an equivalence system of value-based assessment covering educational training, work experience and competency possessed by practitioners of biomedical engineering skills. To facilitate this a large number of assessment centres are being planned across several states in India where competency test on key bio-medical engineering skills could be undertaken by practitioners of bio-medical engineering from mechanical, electronic, electrical, health, IT, clinical and allied engineering subjects. The outcome – a competency score – shall be framed on parity with other such professional bodies in other countries. This equivalence score will help the Indian biomedical skill pool to gain formal recognition and acceptance of their experience and knowledge in other countries.

The tripartite memorandum of understanding (MoU) was signed by Rajiv Nath, forum coordinator, AiMED, Dr. Jitendar Sharma, MD & CEO, AMTZ and Dr. Ravi P. Singh, secretary general, QCI.

According to Nath, healthcare industry is one of the major source of economy to our nation, this industry needs well trained and skilled engineers particularly in medical devices areas.

“The move will help develop skill programs in the areas of medical devices and related areas that full fill the required manpower to hospitals, medical equipment companies and manufacturing industries. This will benefit the manufactures/industries by making available skilled manpower very easily who are well trained as per the requirements. It will also create more job opportunities for our engineers across the globe. It will enhance the competitiveness and profitability of Indian medical device industry,” he added.

Earlier a CT Scan manufacturer in India could not depute his engineer to EU or US to install, commission or service his equipment as his Indian employed engineer was not qualified. Now with this competency certification and international agreements we expect to have we will be able to support our exports as the above issue is acting as a non-tariff trade barrier, said Dr Sharma.

Along with representatives from AMTZ, QCI and AIMED, the first meeting of IBSC had representation from Kalam Institute of Health Technology (KIHT), IIT Guwahati (IIT-G), Indian Institute of Science (IISc), Christian Medical College (CMC), Central Scientific Instruments Organisation (CSIO), Healthcare Sector Skill Council (HSSC), Society for Applied Microwave Electronics Engineering & Research (SAMEER), Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Panjab University, BSI Group, Australian Trade and Investment Commission (Austrade), TÜV Rheinland India and Phoenix Medical Systems.

Indian biomedical skill sector gets a boost

Published By: elets

With the aim to strengthen biomedical skill sector in the country, Indian Bio-medical Skill Consortium (IBSC) was formed recently. Andhra Pradesh MedTech Zone (AMTZ), Quality Council of India (QCI) and Association of Indian Manufacturers of Medical Devices (AIMED), joined hands to form the Consortium.

A Memorandum of Understanding (MoU) was signed among above three partners to form IBSC, which proposes to develop a value-based assessment covering educational training, work experience and competency possessed by practitioners of biomedical engineering skills.

The MoU was signed by Dr. Jitendar Sharma (MD & CEO, AMTZ), Dr. Ravi P. Singh (Secretary General, QCI) and Mr. Rajiv Nath (Forum Coordinator, AIMED)

A large number of assessment centres are being planned across country where competency test would be organised.

The competency test on key bio-medical engineering skills would be undertaken by practitioners of bio-medical engineering from mechanical, electronic, electrical, health, IT, clinical and allied engineering subjects.

On the basis of that, a competency score would be framed on parity with other such professional bodies in other countries.

This equivalence score will help the Indian biomedical skill pool to gain formal recognition and acceptance of their experience and knowledge in other countries.

Namocare’ to boost pharma sector: Ananth Kumar

Published By: DECCAN CHRONICLE.

BENGALURU: Union Chemicals and Fertilisers Minister H.N. Ananth Kumar has said the NDA government’s newly-launched Ayushman Bharat insurance scheme, also known as ‘Namocare’, has the potential to turn India into the largest pharma manufacturer of the world in three years.

After inaugurating the third edition of India Pharma 2018 and India Medical Device 2018, a three-day event that brings together stakeholders in pharma and medical device sectors across the country here on Thursday, the Minister said, “Ayushman Bharat will fundamentally change Indian healthcare. It is laying down an ambitious framework for universal health coverage. The Government will start rolling out the scheme in two months.”

The minister said the Union government is drafting a new pharma policy so as to make necessary changes to implement the health insurance scheme. The minister also said that the country needed a new ministry of Pharma and Medical Devices, as various parts of the industry currently were under the ambit of different ministries. The minister also launched the E-auction portal and Enterprise Resource Planning (ERP) software for Medical Device Manufacturers at the event.

Conceptualised and developed by Kalam Institute of Health Technology (KIHT), the portal shall pool in medical technologies developed in research labs funded by the government to auction them to the Industry, thereby bridging the gap between industry and academia.

The ERP, which was launched free of cost for medical device manufacturers, has been jointly developed by Andhra Pradesh MedTech Zone (AMTZ) and Lotus Wireless and shall help medical device manufacturers reduce internal overhead costs by over 30 per cent.

Industry experts from both pharma and medical device sectors discussed key issues including price capping and medical device regulation.

Regarding the recent price capping by National Pharmaceutical Pricing Authority, Probir Das, Managing Director, Terumo India, who is also the Chair, FICCI Medical Device Forum, said, “There has to be affordability, but not through the merit of a low-cost device. Price capping in its current form is not the answer. We have to align different elements of strategic interaction.” Sunil Khurana, CEO and MD, BPL Medical Technologies, welcomed the Government’s ‘Make In India’ initiative and said, “We have to take the whole world as a global market and hence have to be on par with the global standards.”

UNION MINISTER LAUNCHS E-AUCTION PORTAL & ERP FOR MEDICAL DEVICES SECTOR

Organized by Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India in partnership with Federation of Indian Chambers of Commerce & Industry (FICCI), the India Medical Device 2018 is one of the largest exhibition and conference on the Indian Medical Devices Sector which was inaugurated today at Bangalore. The inaugural session was attended by Shri Ananth Kumar, Union Minister for Chemicals & Fertilizers and Parliamentary Affairs; Shri Mansukh L. Mandaviya, Minister of State for Chemicals & Fertilizers, Road Transport & Highways, Shipping; Dr. Henk Bekedam, WHO Representative to India and a plethora of other guests from the government, industry and trade associations.
The star-studded inaugural session of the India Medical Device 2018 witnessed the launch of two major initiatives for medical devices industry – the world’s first unique e-Auction tech transfer portal exclusively dedicated for Medical Technologies and world’s first med tech Enterprise Resource Planning (ERP) software for Medical Device Manufacturers which is free and developed on open source. Conceptualized and developed by Kalam Institute of Health Technology (KIHT), the e-Auction portal shall pool-in medical technologies developed in research labs funded by Govt. of India and auction them to the Industry, thereby bridging the gap between industry and academia. The auction shall make prototypes and technologies be commercialized and additional source of funding reach to the academic and research institutions. The ERP which has been launched free-of-cost for medical device manufacturers has been jointly developed by Andhra Pradesh MedTech Zone (AMTZ) and Lotus Wireless using open source and shall help medical device manufacturers reduce internal overhead costs by over 30%.
The swift work and progress done at AMTZ and KIHT was applauded by the Union Minister and everybody present at the event. With initiatives such as the e-Auction Portal & ERP being launched and applauded at a platform like the India Medical Device 2018 & India Pharma 2018, showcase to the world that the ‘Make in India’ dream is coming true to reduce the cost of healthcare in the country and world over

Naidu Hot Sells Make In India @ AP To Swiss Medtech In Davos

On the second day of the trip to Davos, Chief Minister Chandrababu Naidu met with delegates of Medtech Innovation Centre, a Swiss based venture investor, specializing in the healthcare sector.

The delegation included Chairman of Medtech Innovation, Dr. Felix Gresard, Board of Director Dr. Hans Florian and CEO Dr. Christoph Kausch.

Medtech Innovation Centre has already signed an MoU with Andhra Pradesh Economic Development Board last year and aim to bring close to 150 companies to Andhra Pradesh.

Officials reported that the progress has been great till now and a letter of intent with about 50 companies have already been signed.

As a part of their phase one, they have already lined up 60 companies and at the end of phase two, all the 150 companies are expected to set up base in Andhra Pradesh.

The Medtech delegation informed the Chief Minister that their primary aim is to create an eco system where companies can flourish. He was also informed that they will be starting with the European segment of the Vizag Medtech Park and will eventually go on to establish their own independent park.

This move is expected to bring employment to 45 to 50 thousand highly skilled technicians and scientists.

We welcome high precision Swiss MedTech in India and Indian partners will surely succeed with collaborations with mid sized and small European/ Japanese/Taiwanese /Korean and Israeli Co – they prosper well and will eye the Large Indian market – the big US MNCd will wait and watch and walk in last to buy out successful cos – they are too lazy for efforts needed for Greenfield – glad GoAP under Leadership of CM Naidu and advisory of Dr Poonam & Dr Jitendra Sharma has got its strategy correct” Said Rajiv Nath ,Forum Coodinator,AiMeD

AP govt signs MoU with AERB to set up directorate of radiation safety at AMTZ

The government of Andhra Pradesh has recently entered into a Memorandum of Understanding with Atomic Energy Regulatory Board (AERB) to set up the Directorate of Radiation Safety (DRS) at India’s first medical device park, Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam.

Under this agreement, the directorate staff shall be supported and trained by AERB to undertake regulatory inspections and verify compliance of the various x-ray installations in the state. With the setting up of DRS at AMTZ, the manufacturers of radiological equipment shall be immensely benefited towards certifications for their products. The safety in hospitals is set to get a boost with this initiative.

AERB has a mandate to ensure that the use of ionizing radiation and nuclear energy in India does not cause undue risk to health and the environment. With this, Andhra Pradesh joins the elite group for hosting the directorate of radiation safety for AERB.

The recognition plaque was handed over by Dr. Avinash U. Sonawane, head, Directorate of Regulatory Affairs & Communications, AERB to Dr. Jitendar Kumar Sharma, CEO, AMTZ and Dr. Poonam Malakondaiah, principal secretary, Department of Health, Medical & Family Welfare, Government of Andhra Pradesh in the presence of Chief Minister of Andhra Pradesh, N Chandra Babu Naidu.

An MoU was also recently signed between Engineering Export Promotion Council of India (EEPC) and Andhra Pradesh MedTech Zone (AMTZ) to drive ‘Made in India’ exports of medical technology products.

This is envisaged to provide much-needed support for Indian medical device manufacturers to increase export of ‘Made in India’ products to cater to global medical device demand of approximately Rs.30 lakh crore.

The partnership will enable manufacturers at AMTZ with access to global exhibitions, export promotion events etc. where Indian medical technology products can be showcased, with support from EEPC.

As part of the agreement, AMTZ would provide EEPC with support in the areas of domestic regulations and technical support relating to medical devices sector. This partnership paves the way for creating an export promotion body for medical devices which will ensure that Indian medical devices can compete to satisfy global demand.

AMTZ has already put in place best in class infrastructure, scientific facilities, regulatory support and preferential market access will also enable manufacturers to export globally with this partnership.

Directorate of Radiation Safety to be set-up in Andhra Pradesh

The Department of Health, Medical & Family Welfare (HM & FW), Andhra Pradesh has signed a Memorandum of Understanding with the Atomic Energy Regulatory Board (AERB) for setting up the Directorate of Radiation Safety (DFS) to regulate functioning of x-ray installations in the state.

AERB has mandate to ensure that the use of ionizing radiation and nuclear energy in India does not cause risk to health and the environment.

According to MoU, AERB will support and train the Directorate staff and will undertake regulatory inspections and verify compliance of the various x-ray installations in the state.

The Directorate will be set-up at AMTZ in Visakhapatnam. This will benefit the manufacturers of radiological equipment towards certifications for their products. The safety in hospitals is set to get a boost with this initiative.

The recognition plaque was handed over by Dr. Avinash U. Sonawane, Head, Directorate of Regulatory Affairs & Communications, AERB to Dr. Jitendar Kumar Sharma, MD & CEO, AMTZ and Dr. (Smt.) Poonam Malakondaiah, IAS, Principal Secretary, Department of Health, Medical & Family Welfare, Government of Andhra Pradesh in the august presence of Hon’ble Chief Minister of Andhra Pradesh, Sri N. Chandra Babu Naidu.

AP FIRST IN MANY TO GET RADIATION SAFETY DIRECTORATE

Andhra Pradesh joins the elite group to host the Directorate of Radiation Safety (DRS) for the Atomic Energy Regulatory Board (AERB). The Department of Health, Medical & Family Welfare (HM & FW), Government of Andhra Pradesh, entered into a Memorandum of Understanding with AERB today to formally set up the DRS which shall be housed at Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam. The recognition plaque was handed over by Dr. Avinash U. Sonawane, Head, Directorate of Regulatory Affairs & Communications, AERB to Dr. Jitendar Kumar Sharma, MD & CEO, AMTZ and Dr. (Smt.) Poonam Malakondaiah, IAS, Principal Secretary, Department of Health, Medical & Family Welfare, Government of Andhra Pradesh in the august presence of Hon’ble Chief Minister of Andhra Pradesh, Sri N. Chandra Babu Naidu.
AERB has a mandate to ensure that the use of ionizing radiation and nuclear energy in India does not cause undue risk to health and the environment. Under this agreement, the Directorate staff shall be supported and trained by AERB to undertake regulatory inspections and verify compliance of the various x-ray installations in the state. With the setting up of DRS at AMTZ, the manufacturers of radiological equipment shall be immensely benefited towards certifications for their products. The safety in hospitals is set to get a boost with this initiative.

AMTZ and EEPC join hands to drive ‘Made in India’ exports

Andhra Pradesh MedTech Zone (AMTZ) and Engineering Export Promotion Council of India (EEPC) have entered into a Memorandum of Understanding (MoU) to drive ‘Made in India’ exports of medical technology products.

The MoU was signed by Dr Jitendar Sharma, Managing Director and CEO, AMTZ and Bhaskar Sarkar, Executive Director and Secretary, EEPC India, at New Delhi on November 22.

Under the agreement, EEPC India will provide support for export promotion, trade facilitation, market access facilitation to manufacturers at AMTZ, while AMTZ would provide EEPC with support in the areas of domestic regulations and technical support relating to medical devices sector.

This partnership will enable manufacturers at AMTZ with access to global exhibitions, export promotion events, etc, where Indian medical technology products can be showcased, with support from EEPC India.

This partnership also paves the way for creating an export promotion body for medical devices, which will ensure that Indian medical devices can compete to satisfy global demand.

AMTZ, which is a member of the BRICS (Brazil, Russia, India, China and South Africa) manufacturing working group from India, was recently selected by World Health Organisation to setup the Pre-Qualification Cell for In Vitro Diagnostics, which is a first of its kind in South East Asia.

AMTZ is focused on building the medical technology ecosystem in India to cater to both local demand and export of Made in India products.

EEPC is the premier trade and investment promotion organisation in India. It is sponsored by the Ministry of Commerce and Industry, Government of India and caters to the Indian engineering sector. As an advisory body it actively contributes to the policies of Government of India and acts as an interface between the engineering industry and the Government.

In vitro diagnostics: AMTZ to host WHO’s pre-qualification cell

World Health Organisation has selected Andhra Pradesh MedTech Zone (AMTZ), which is setting up medical devices manufacturing unit near Visakhapatnam Steel Plant, to host its pre-qualification cell for in vitro diagnostics (IVD). The programme of WHO is aimed at promoting and facilitating access to safe, appropriate and affordable in vitro diagnostics of good quality in an equitable manner.

It focuses on in vitro diagnostics for priority diseases such as HIV, malaria, hepatitis B and C and their suitability to use in resource-limited settings. It undertakes a comprehensive assessment of in vitro diagnostics through a standardised procedure.

IVD is the first of its kind in South East Asia. The cell at AMTZ was officially announced by WHO during the first World Conference on Access to Medical Products and International Laws for Trade and Health in New Delhi on Wednesday. A citation plaque was presented by WHO to AP Principal Secretary, Health, Medical and Family Welfare Poonam Malakondaiah and APTZ Managing Director and CEO Jitendar Sharma.

Nadda For More Investment, Players In Medical Devices Sector

“India is deeply committed nationally and globally to achieving all public health goals and also focusing on developing India as a hub for affordable medical devices.” This was stated by J P Nadda, Union Minister of Health and Family Welfare at the inauguration of ‘1st World Conference on Access to Medical Products and International Laws for Trade and Health in the Context of the 2030 Agenda for Sustainable Development’, here. The Health Minister further stated that there is a need for promoting industry and academia collaboration for developing affordable medical products such that innovations and advances in medical sector reach a vast population.

Anupriya Patel, Minister of State (HFW), Dr. V.K. Paul, Member, NITI Aayog, Government. of India, Preeti Sudan, Secretary (Health), Dr. Soumya Swaminathan, Secretary, Dept. of Health & Research (DHR) and DG, ICMR and Dr. Jagdish Prasad, Director General Health Services also graced the occasion.

Highlighting the importance of transparency between regulatory authorities and pharma sector, Nadda stated that the coordination between the National Regulatory Authorities and pharmaceutical sector will enable launch and registration of new health technologies. He further said that the dialogue on role of competition in competitive pricing and discussion on related WTO agreements influencing health should lead to a larger umbrella of suggested policy options for the government.

Nadda stated that the 2015 National Medical Device Policy will enable local manufacture in the multiproduct, multidisciplinary industry. “In India, nearly 150 thousand orthopaedic knee procedures are done every day. More investments and more players in the medical devices sector will lead to lowering down of prices and access to medical products as most of the governments are sensitive to access and pricing of medical products,” he added.

Addressing the conference via video link, Ashwini Kumar Choubey, Minister of State (HFW) said that research and development in public health should focus on two main aspects. To enable safe, effective and quality medical products for the diseases and rolling out the innovations and inventions along with the learning’s from the field to the people. He further stated that the research and development should focus on making the cost of medical devices/products affordable to the people and highlighted the issue of Anti-microbial Resistance (AMR).

Speaking at the function, Anupriya Patel, Minister of State (HFW), stated that India is committed to attainment of the highest possible standards of health for its citizens. She further said that at the national level, access to medical products (medicines, vaccines, medical devices & diagnostics) is an important facet in the health system as a whole and at the international level, access to medical products is a critical factor for the success of the 2030 sustainable development goals agenda that aims to ensure healthy lives and to promote well-being of people of all ages.

Dr. V.K. Paul, Member, NITI Aayog, Government. of India stated that there is a need for investment in medical products for preventive therapy and treatment and highlighted the importance of affordability, quality, domestic production capacity and to create an eco-system of policy and innovation for greater accessibility of affordable medical drugs and devices. Dr V K Paul further said that technology is an integral block for strengthening medical systems in any country and must also ensure timely maintenance of medical equipment by suppliers in remote and rural areas such that equipment functions effectively.

Preeti Sudan, Secretary (Health) spoke about the issues of access of medicines and medical products. She said that safe medical products should be available at affordable prices. She further reiterated that the Health Ministry is committed to robust regulatory systems for ensuring safety, quality and efficacy of drugs.

Dr. Soumya Swaminathan, Secretary (DHR) and DG, ICMR highlighted issues such as how to use TRIPs flexibilities; alternative models for affordable medicines and devices such as voluntary licensing; clear predictable regulatory pathways; more investment in R&D and publicly funded R&D; innovative healthcare service delivery models; anti-biotic stewardship; and collaboration between the public and private sectors including academia to reduce cost of production and delivery.

The Conference is being organized by the Ministry of Health & Family Welfare with the support of WHO Country Office for India and in partnership with Indian Society of International Law. The objective of the Conference is to exchange knowledge and expand understanding on contemporary issues in international trade laws and research and innovation for access to medical products to achieve SDG 2030 agenda.

WHO selects AMTZ to host pre-qualification cell for in vitro diagnostics

The World Health Organization (WHO) has selected Andhra Pradesh MedTech Zone Ltd (AMTZ), India’s first government funded medical devices manufacturing park, to host its pre-qualification cell for In Vitro Diagnostics (IVD) which is a first of its kind in South East Asia.

This pre-qualification cell, which will provide guidance to Indian manufacturers on the WHO pre-qualification of IVDs Programme and will also enable manufacturers to match global quality standards. It will also help manufacturers to participate in UN procurement process for IVD devices enabling export.

WHO will provide the required training to the support cell staff to guide the manufacturers about WHO pre-qualification expectations while AMTZ will handle day to day operations. AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

The cell at AMTZ was officially announced by WHO during the ‘1st World Conference on Access to Medical Products and International Laws for Trade and Health’ organised in New Delhi recently.

The IV Diagnostics segment has an estimated market value of Rs.3.54 lakh crore globally out of which India contributes an estimated Rs.2,550 crore. Exports from India in the IVD segment were at Rs.254 crores in FY16 which leaves a huge export opportunity of approximately Rs.3 lakh crore for Indian manufacturers to tap into.

WHO pre-qualification of IVDs Programme aims to promote and facilitate access to safe, appropriate and affordable in vitro diagnostics of good quality in an equitable manner. The programme focuses on in vitro diagnostics for priority diseases such as HIV, malaria, hepatitis B and hepatitis C, and their suitability for use in resource-limited settings. It undertakes a comprehensive assessment of in vitro diagnostics through a standardized procedure aimed at determining if the product meets WHO pre-qualification requirements.

AMTZ will soon set up eight medical device testing labs under one roof. This will provide medical device testing facilities to around 180 companies at AMTZ in the coming eight months time.

Currently 38 companies have set up 53 units in AMTZ which has a total capacity of 180 companies. These companies can set up a total 240 units in the coming time. A comprehensive facility to test all medical devices under one roof will also be provided to the companies in AMTZ in coming eight months time.

AMTZ gets World Health Organisation recognition

Andhra Pradesh MedTech Zone Ltd (AMTZ) has been selected by the World Health Organisation (WHO) to host their pre-qualification cell for In Vitro Diagnostics (IVD) — a first-of-its-kind facility in South East Asia.

WHO officially announced the cell at AMTZ during the first World Conference on Access to Medical Products and International Laws for Trade and Health at New Delhi on Wednesday.

The establishment of pre-qualification cell will provide guidance to Indian manufacturers on the WHO Pre-Qualification of In Vitro Diagnostics (IVDs) Programme, enabling manufacturers to match global quality standards and also participate in UN procurement process for IVD devices.

The IV Diagnostics segment has an estimated market value of Rs 3.54 lakh crores globally out of which India contributes an estimated Rs 2,550 crores. Exports from India in the IVD segment were at Rs 254 crores in FY16 which leaves a huge export opportunity of approximately Rs 3 lakh crores for Indian manufacturers to tap into.

WHO will provide the required training to the support cell staff to guide the manufacturers about WHO Prequalification expectations while AMTZ will handle day to day operations.

A citation plaque was presented by WHO to Dr Poonam Malakondaiah, Principal Secretary Health Medical & Family Welfare, Government of Andhra Pradesh and Dr Jitendar Sharma, MD & CEO, AMTZ, to commemorate the occasion.

The WHO Prequalification of In Vitro Diagnostics (IVDs) Programme aims to promote and facilitate access to safe, appropriate and affordable in vitro diagnostics of good quality in an equitable manner.

The programme focuses on in vitro diagnostics for priority diseases such as HIV, malaria, hepatitis B and hepatitis C, and their suitability for use in resource-limited settings. It undertakes a comprehensive assessment of in vitro diagnostics through a standardised procedure aimed at determining if the product meets WHO prequalification requirements.

Launch of KIHT a major boost towards making India a global manufacturing hub for medical devices: AiMeD

The recently launched Kalam Institute of Health Technology (KIHT), India’s first institute dedicated to medical technology located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, will prove to be a major boost towards making India a global manufacturing hub for medical devices, according to the Association of Indian Medical Device Industry (AiMeD), an association of medical devices manufacturers in the country.

Named after India’s 11th President Dr APJ Abdul Kalam, KIHT has been set up with the aim to identify critical gaps in medical technology and suggest the government to do focused spending on such areas and help bridge the gap between academic research and industrial market access, by auctioning of patents and prototypes available with government funded academic research institutions.

Congratulating KIHT on its formal launch, Rajiv Nath, Forum Coordinator, AiMED said “We are extremely happy that the 1st Governing Body meet of KIHT is a major step towards making India a global manufacturing hub for medical device sector and to build a robust system for innovation in the medical devices sector in the country.”

AiMeD, representing the Indian medical device industry, is also on KIHT’s Governing Board and will spearhead and coordinate the indigenous development of medical devices. In the first Governing Body meeting held in Delhi recently, KIHT has been identified as nodal point for medical technology program support cell for national biopharma mission; KIHT has been accepted as the facilitator for DBT/BIRAC funded innovations for helping them with certifications; and there was an approval accorded for technology e-auction.

KIHT is being guided by stalwarts of the scientific community like Dr. R. Chidambram, Principal Scientific Advisor to Government of India as president and the Governing Body members include: Prof. Vijay Raghavan – Secretary Department of Biotechnology (DBT) as chairperson; Dr Poonam Malakondaiah – Principal Secretary (HM&FW), Govt. of Andhra Pradesh; Dr.Renu Swarup – Senior Advisor, DBT & MD, BIRAC; Rajiv Agarwal – Joint Secretary, Department of Industrial Policy & Promotion (DIPP), Govt. of India; Dr. Swati Basu – Scientific Secretary, Office of Principal Scientific Adviser to Govt. of India; Rajiv Nath – Forum Coordinator, AIMED; Prof. B. Ravi – Institute Chair Professor, IIT Bombay, Mumbai; Prof.Balaram Bhargava – Executive Director, School of International Bio-Design, AIIMS, New Delhi and Dr. Jitendar Sharma – Managing Director & CEO, AMTZ, Visakhapatnam as Executive Director.

The Governing body led by Prof. Vijay Raghavan applauded the conceptualization and idea of KIHT to support government of India for focused R&D policy in the medical devices sector through its Cell for Research and Development (CRD).

AMTZ soon to house eight medical device testing labs in India’s first medical device park

The Andhra Pradesh MedTech Zone (AMTZ) – India’s first government funded medical devices manufacturing park, will soon set up eight medical device testing labs under one roof. This will provide medical device testing facilities to around 180 companies at AMTZ in the coming eight months time.

“Currently 38 companies have set up 53 units in AMTZ which has a total capacity of 180 companies. These companies can set up a total 240 units in the coming time. A comprehensive facility to test all medical devices under one roof will also be provided to the companies in AMTZ in coming eight months time,” says a senior official associated with the development.

AMTZ has also inked formal agreements with the various scientific facilities which will be housed within the country’s first Medical Technology Manufacturing Park spread over 270 acre.

Scientific facilities include Centre for Electro-Magnetic Interference/ Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for Biomaterials Testing, Centre for X-ray and CT Scan Tube Manufacturing, Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling, Centre for Gamma Irradiation and AMTZ Central Warehouse.

As on date, 23 devices have been notified by the Central government. The notified devices are required to be registered prior to sale, whereas those not notified can be sold without registration.

The AMTZ with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40 per cent to 50 per cent.

Kalam Institute of Health Technology (KIHT), India’s first institute dedicated to medical technology located at AMTZ, Visakhapatnam which recently held its 1st Governing Body meeting in Delhi, is also working towards building a robust system for innovation in the medical devices sector in the country. It recently received 100 per cent financial support from the Department of Biotechnology (DBT).

The Governing body led by Prof. Vijay Raghavan hailed the uniqueness of the KIHT model in bringing academia and industry together. The Governing Body members applauded the conceptualization and idea of KIHT to support Government for focussed R&D policy in the medical devices sector through its Cell for Research and Development (CRD).

KIHT’s Cell of Technology Transfer (CTT) will facilitate academia with rapid technology transfer and product certifications, while the Cell for Innovation and Market Access (CIM) will enable industry with technology access and drive innovation of next generation of medtech products. The Cell for Market Intelligence and Trade (CMT) will work with respective department/ministry towards elimination of trade barriers. CMT will also undertake research and analysis of relevant data to help in developing long term strategies for the medical device industry.

KIHT is working towards hosting a first of its kind congregation of innovators, investors and manufacturers for technology transfer from academia to industry for commercialization. KIHT’s proposition is further strengthened through its partnership with Association of Indian Medical Device Manufacturers (AIMED) which brings access to technical bandwidth from the industry and opportunities for deeper collaboration with the medical device industry.

AMTZ and ADMI strike a strategic partnership

Kalam Institute of Health Technology (KIHT) which is currently hosted by AMTZ will partner with ADMI to enable technology transfer, focused research and development in the IVD sector.
Andhra Pradesh MedTech Zone (AMTZ) has signed a Memorandum of Understanding (MoU) with the Association of Diagnostic Manufacturers of India (ADMI) for improving access to technological, investment opportunities, and help build strategic, long-term partnership between ADMI and AMTZ.The MoU was signed by Dr. Jitendar Sharma, CEO, AMTZ and Dr. D. K. Joshi, President, ADMI, during the recent quarterly meeting of members of ADMI at Mumbai.

As per the MoU, AMTZ and ADMI will work together to identify and add Harmonized System (HS) codes for IVD products. This will enable easier classification of IVD products and reduce complexity during their trade.

AMTZ with its one-stop solution across infrastructure, scientific facilities, regulatory help desk and preferential market access is enabling the entire ecosystem for medical devices while ADMI with its focus and expertise in IVD devices will partner to promote the standards of the IVD industry in India.

ADMI which represents companies from the Indian IVD industry will be setting up an office at AMTZ. It will also be contributing towards the proposed National Medical Device Promotion Council (NMDPC) to promote industry and assist with trade barriers. Kalam Institute of Health Technology (KIHT) which is currently hosted by AMTZ will partner with ADMI to enable technology transfer, focused research and development in the IVD sector.

AMTZ has been allotted 270 acres to become a hub for ultra modern medical equipment manufacturing. The project is envisaged to attract at least 200 units with an estimated investment of Rs.25,000 crore to Rs.30,000 crore and job opportunities for 25,000 people.

AMTZ signs MoU with ADMI for boosting investment opportunities for Indian IVD industry

Andhra Pradesh MedTech Zone (AMTZ) has signed an MoU with Association of Diagnostic Manufacturers of India (ADMI) for improving access to technological, investment opportunities, and help build strategic, long-term partnership between ADMI and AMTZ.

AMTZ with its one-stop solution across infrastructure, scientific facilities, regulatory help desk and preferential market access is enabling the entire ecosystem for medical devices while ADMI with its focus and expertise in IVD devices will partner to promote the standards of the IVD industry in India.

As per the MoU, AMTZ and ADMI will work together to identify and add Harmonized System (HS) codes for IVD products. This will enable easier classification of IVD products and reduce complexity during their trade.

The MoU was signed by Dr. Jitendar Sharma, CEO, AMTZ and Dr. D. K. Joshi, President, ADMI, during the recent quarterly meeting of members of ADMI at Mumbai.

ADMI which represents companies from the Indian IVD industry will be setting up an office at AMTZ. It will also be contributing towards the proposed National Medical Device Promotion Council (NMDPC)to promote industry and assist with trade barriers. Kalam Institute of Health Technology (KIHT) which is currently hosted by AMTZ will partner with ADMI to enable technology transfer, focused research and development in the IVD sector.

ADMI which aims to provide a platform for the Indian IVD manufacturers so that they can voice their concerns and resolve issues. It also works to foster understanding of the IVD industry within its members and also among all stake holders both nationally and internationally.

AMTZ has been allotted 270 acres to become a hub for ultra modern medical equipment manufacturing. The project is envisaged to attract at least 200 units with an estimated investment of Rs.25,000 crore to Rs.30,000 crore and job opportunities for 25,000 people.

The park will be developed as an Electronic Manufacturing Cluster, the first after the one proposed at Gurrampalem near Pendurthi in Visakhapatanam. AMTZ will be an import substitute for medical devices being brought from the Europe, the US, Germany and China.

The zone will have separate labs for electro-magentic interference/compatibility, gamma irradiation, X-ray/CT scan tube manufacturing, radiated emissions, conducted emission, 3D design, prototyping and rapid tooling facility and central warehousing, exhibition and seminar halls, regulatory offices and export import promotion body.

AMTZ an initiative of the State government to attract medical devices manufacturing units to Visakhapatnam will bring down the cost of healthcare by at least 40 per cent. It has also joined the elite club of BRICS Working Group on Manufacturing from India.

The BRICS is an association of five major economies – Brazil, Russia, India, China, and South Africa. It has seven working groups in the areas of infrastructure, manufacturing, financial services, energy and green economy, skill development, agribusiness, and deregulation under the aegis of the BRICS Business Council.

The BRICS Business Council, which was set up during the Fifth BRICS Summit held in Durban, South Africa in March, 2013 was aimed at creating a platform to promote and strengthen ties among the member countries.

Med-tech zones set to boost business growth prospects for start-up enterprises: M Balasubramaniam

Med-tech zones in the country are set to boost business growth prospects for start-up companies engaged in designing and developing critical healthcare equipment, said M Balasubramaniam, president and CEO, CURA Healthcare.

The company was one among the participants at the launch of the Andhra Pradesh MedTech Zone (AMTZ) which is India’s first medical devices manufacturing unit spread over 270 acre in Visakhapatnam. “In fact we have taken a facility here for manufacturing,” he added.

In sync with the Union government’s Make in India programme, CURA Healthcare went on to manufacture Illumina 3600 which is the world’s first-ever robotic 360 degree Breast Thermography system. Many companies from India and multinational companies have taken advantage of it to Make in India. We are one such company that well entrenched into it and would welcome more enterprises to be part of it, Balasubramaniam told Pharmabiz in an email.

Local manufacture drives economies-of-scale, creates jobs, provides control over supply chain and enables cost competitiveness. “We have been making tremendous progress over the years. It has taken about 7 years to develop this product. This is a solution designed, developed and manufactured 100% by CURA Healthcare. There is no technology transfer from any country. The camera component is imported and tuned for illumina. The final product is priced around Rs. 30 lakh to Rs. 35 lakh similar to that of an analog mammography system.

In this advanced robot, the protocol is set to allow maximum comfort to patients. There is also an environmental control system that allows dual temperature studies identifying changes during mild hot and cold conditions. There are drawbacks in the equipment manufactured abroad like only few images can taken and the chances of failing to spot key  tissues is high. To offset the same, we have developed advanced algorithms that aid the physician to auto-detect a cancerous tissue early or compare with historical exams and compare with other images for correlation, he explained.

“The way forward is to scout for tie-ups with government hospitals and talks are underway. With illumina being funded by the Union government, we believe this can disrupt the way breast health is being managed today. As a Make in India effort and as a for India product, clinical trials were done on over 10,000 patients across 6 institutions. The final analysis is that our Breast Thermography system is shown to be 97% accurate and can find tissues below 2 mm size. It is a complementary technology for mammography and other structural imaging tools,” he said.

Going by the morbidity and mortality of breast cancer in the world, the company is keen to ensure that patients globally can benefit from early detection and radiation free screening, said Balasubramaniam.

A.P. MedTech Zone joins elite club of BRICS Working Group

It is expected to be a hub for ultra modern medical equipment manufacturing
The Andhra Pradesh MedTech Zone, an initiative of the State government to attract medical devices manufacturing units to Visakhapatnam to bring down the cost of healthcare by at least 40%, has joined the elite club of BRICS Woking Group on Manufacturing from India.

The BRICS is an association of five major economies – Brazil, Russia, India, China, and South Africa. It has seven working groups in the areas of infrastructure, manufacturing, financial services, energy and green economy, skill development, agribusiness, and deregulation under the aegis of the BRICS Business Council. An official of the AMTZ told The Hindu on Thursday that they would be part of an elite group, comprising Tata, Mahindra & Mahindra, Birla, and Apollo Tyres.

The BRICS Business Council, which was set up during the Fifth BRICS Summit held in Durban (South Africa) in March, was aimed at creating a platform to promote and strengthen ties among the member countries.

AMTZ, which is in the process of finalising tenders for its first phase of construction at Nadupuru village near here, where it has been allotted 270 acres early this year, is expected to become a hub for ultra modern medical equipment manufacturing.

Estimated investment

The project is envisaged to attract at least 200 units with an estimated investment of ₹25,000 crore to ₹30,000 crore and job opportunities for 25,000 people.

The park will be developed as an Electronic Manufacturing Cluster, the first after the one proposed at Gurrampalem near Pendurthi in the city. AMTZ will be an import substitute for medical devices being brought from the Europe, the US, Germany, and China.

The zone will have separate labs for electro-magentic interference/compatibility, gamma irradiation, X-ray/CT scan tube manufacturing, radiated emissions, conducted emission, 3D design, prototyping and rapid tooling facility and central warehousing, exhibition and seminar halls, regulatory offices and export import promotion body.

A.P. MedTech Zone joins elite club of BRICS Working Group

It is expected to be a hub for ultra modern medical equipment manufacturing

The Andhra Pradesh MedTech Zone, an initiative of the State government to attract medical devices manufacturing units to Visakhapatnam to bring down the cost of healthcare by at least 40%, has joined the elite club of BRICS Woking Group on Manufacturing from India.

The BRICS is an association of five major economies – Brazil, Russia, India, China, and South Africa. It has seven working groups in the areas of infrastructure, manufacturing, financial services, energy and green economy, skill development, agribusiness, and deregulation under the aegis of the BRICS Business Council. An official of the AMTZ told The Hindu on Thursday that they would be part of an elite group, comprising Tata, Mahindra & Mahindra, Birla, and Apollo Tyres.

The BRICS Business Council, which was set up during the Fifth BRICS Summit held in Durban (South Africa) in March, was aimed at creating a platform to promote and strengthen ties among the member countries.

AMTZ, which is in the process of finalising tenders for its first phase of construction at Nadupuru village near here, where it has been allotted 270 acres early this year, is expected to become a hub for ultra modern medical equipment manufacturing.

Estimated investment

The project is envisaged to attract at least 200 units with an estimated investment of ₹25,000 crore to ₹30,000 crore and job opportunities for 25,000 people.

The park will be developed as an Electronic Manufacturing Cluster, the first after the one proposed at Gurrampalem near Pendurthi in the city. AMTZ will be an import substitute for medical devices being brought from the Europe, the US, Germany, and China.

The zone will have separate labs for electro-magentic interference/compatibility, gamma irradiation, X-ray/CT scan tube manufacturing, radiated emissions, conducted emission, 3D design, prototyping and rapid tooling facility and central warehousing, exhibition and seminar halls, regulatory offices and export import promotion body.

AMTZ JOINS THE ELITE CLUB OF BRICS WORKING GROUP

Andhra Pradesh MedTech Zone (AMTZ) was made part of the BRICS Working Group on Manufacturing from India. BRICS, which is an association of five major emerging national economies: Brazil, Russia, India, China and South Africa has seven working groups in the areas of Infrastructure, Manufacturing, Financial Services, Energy & Green Economy, Skills Development, Agribusiness and Deregulation, which have been formed under the aegis of the BRICS Business Council.
AMTZ joins an elite group consisting of global leaders like Tata, Mahindra & Mahindra and Birla and Apollo tyres, in the manufacturing domain. AMTZ now brings a focus on medical technology manufacturing to facilitate investment from BRICS countries to promote industrial development and job creation. The BRICS Business Council was established during the Fifth BRICS Summit held on 26th – 27th March 2013 in Durban, South Africa where the Prime Ministers of the five countries participated. The objective of creating the council was to constitute a platform which will promote and strengthen business, trade and investment ties amongst the business communities of the five BRICS countries, facilitate dialogue between the business communities of the BRICS nations identify barriers to ensure greater economic, trade and investment ties amongst the BRICS countries.
AMTZ became the first medical technology agency to become a member of the BRICS Working Group from India in recognition of the fact that AMTZ has been the leader in strengthening a heavily import dependent and highly complex medical devices sector in India and front runner on medical technology investments and infrastructure development. With Kalam Institute of Health Technology for technology transfers, and now with BRICS working group membership, AMTZ continues to strengthen itself as a fulcrum of medical technology advancement. With eminent scientists working in its various portfolios, AMTZ holds a key position in Indian medical technology policy landscape.

AMTZ signs MoU with Medikabazaar to enhance access of medical equipments through digital channel

Andhra Pradesh MedTech Zone (AMTZ), India’s 1st integrated medical devices manufacturing park coming up in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with Medikabazaar for enabling access to demand-supply of medical equipment through digital channels. The MoU was signed by Dr. Jitendar Sharma, CEO, AMTZ and Vivek Tiwari, CEO, Medikabazaar.

This MoU enables manufacturers at AMTZ with access to the Medikabazaar platform which is an online aggregator of medical supplies enabling procurement and purchase of medical supplies beyond geographical boundaries. The MoU which was signed during the Medicall Mumbai 2017 event facilitates manufacturers at AMTZ with access to demand and supply transactions of medical equipment through the digital medium.

Medikabazaar is India’s largest online aggregator of medical supplies, offering a host of benefits and services to hospitals, medical establishments and consumers. It not only offers medical supplies but also provides the customer with easy access to newly developed technologies all over the world as well as comparison options based on product features and prices.

AMTZ which is a ‘One-Stop- Solution’ for medical device manufacturing aims to reduce the cost of manufacturing up to 40% and simplify the end-to- end operations. AMTZ also include facilities such as electro-magnetic interference laboratory, 3D designing and printing for medical grade products, X-ray tube and radiation testing centre, rapid prototyping centre, metal molding and metal finishing centre, warehousing and regulator’s office.

AMTZ recently signed a Memorandum of Understanding with the Indian Institute of Technology, Bombay (IIT-B) for accelerating medical device innovation and commercialization within the country.

Startups in the field of medical technology which are part of the IITB incubator programme will also benefit from the large integrated ecosystem being provided by AMTZ. This partnership will contribute positively towards the development of the overall medical technology ecosystem in the country.

AMTZ also has the distinction of becoming the second Indian park to become a full-time member of the International Association of Science Parks and Areas of Innovation (IASP). With AMTZ becoming a member of IASP, new business opportunities for companies and research organisations located within AMTZ and in Andhra Pradesh will be enhanced. This will also be a boost for development and growth of areas of innovation.

IASP is a membership-based global network for science parks and areas of innovation to drive growth, innovation and effectiveness. Headquartered at Málaga, Spain, IASP is headed by Josep Miquel Piqué as its President and Luis Sanz as the Director General.

Incorporated on 30 April 2016, AMTZ is an enterprise under the Government of Andhra Pradesh, a 270 acre zone, dedicated for medical device manufacturing.

AMTZ Signs MoU With Medikabazaarfor Enabling Manufacturers With Access To Demand-Supply Of Medical Equipment Through The Digital Channel

Andhra Pradesh MedTech Zone (AMTZ), India’s 1st Integrated Medical Devices Manufacturing Park which is being setup in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with Medikabazaarfor enabling access to demand-supply of medical equipment through digital channels. The MoU was signed by Dr.Jitendar Sharma, Managing Director &CEO, AMTZ and Mr. Vivek Tiwari, CEO,Medikabazaar.

This MoU enables manufacturers at AMTZ with access to the Medikabazaar platform which is an online aggregator of medical supplies enabling procurement and purchase of medical supplies beyond geographical boundaries. The MoU which was signed during the Medicall Mumbai 2017 event facilitates manufacturers at AMTZ with access to demand and supply transactions of medical equipment through the digital medium.

Medikabazaar is India’s largest online aggregator of medical supplies, offering a host of benefits and services to hospitals, medical establishments and consumers. Medikabazaar not only offers medical supplies but also provides the customer with easy access to newly developed technologies all over the world as well as comparison options based on product features and prices.

AMTZ which is a ‘One-Stop- Solution’ for medical device manufacturing aims to reduce the cost of manufacturing up to 40% and simplify the end-to- end operations. AMTZ would also include facilities such as electro-magnetic interference laboratory, 3D designing and printing for medical grade products, X-ray tube and radiation testing centre, rapid prototyping centre, metal molding and metal finishing centre, warehousing and regulator’s office.

AMTZ signs MoU with BRIT for setting up radiation processing facility

Andhra Pradesh MedTech Zone (AMTZ), India’s first integrated medical devices manufacturing park which is being setup in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with the Board of Radiation and Isotope Technology (BRIT) for setting up of one radiation processing facility for medical products in India using Cobalt–60 irradiation technology for large scale irradiation.

The MoU was signed by Dr Jitendar Sharma, Managing Director and CEO, AMTZ and G Ganesh, Chief Executive, BRIT.

This MoU enables manufacturers at AMTZ with access to a first of its kind, world class Gamma irradiation facility, which is being setup in a Public-Private-Partnership (PPP) mode in India.

This facility will be available at a highly subsidised rate for all manufacturers who will be manufacturing at AMTZ. Gamma irradiation enables fast turnaround time and is highly effective because of its ability to easily penetrate package and product.

Under the MoU BRIT will help AMTZ with process technology, training to plant operators and support in establishing and standardising dosimetry.

BRIT is an independent unit of Department of Atomic Energy (DAE) which provides products and services based on radiation and isotopes for applications in healthcare, agriculture, research and industry.

AMTZ would also include facilities such as electro-magnetic interference laboratory, 3D designing and printing for medical grade products, X-ray tube and radiation testing centre, rapid prototyping centre, metal molding and metal finishing centre, warehousing and regulator’s office.

AMTZ signs MoU with NPC to accelerate medical device innovation in India

Andhra Pradesh MedTech Zone (AMTZ), India’s first integrated medical devices manufacturing park which is being setup in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with the National Productivity Council (NPC) to contribute towards creating and sustaining the medical device eco-system in the country and support domestic manufacturing of medical devices.

The MoU was signed by Dr Jitendar Sharma, Director and CEO, AMTZ and Kalpana Awasthi, Director General, NPC. This MoU will enable manufacturers at AMTZ to access solutions for accelerating their productivity.

The large integrated ecosystem being provided by AMTZ will be greatly complemented by the expertise at NPC to help medical device manufacturers enhance competitiveness, augment safety and reliability while ensuring better quality of products through training.

NPC’s core focus of productivity as a means to improving triple bottom line of economic, environmental and social is aligned with AMTZ’s objectives of making healthcare affordable and accessible while placing India on the global map of high end medical equipment production.

AMTZ would include facilities such as electro-magnetic interference laboratory, 3D designing and printing for medical grade products,X-ray tube and radiation testing centre, gamma irradiation facility, rapid prototyping centre, metal molding and metal finishing centre, warehousing and regulator’s office.

NPC is national level organization to promote productivity culture in India. Promotional and catalytic in nature, NPC’s services have bearings on economic growth and quality of life. NPC’s thrust is on providing modern and high-quality productivity-related services to sectors not adequately addressed by others.

AMTZ Signs MoU With National Productivity Council For Enabling Consultancy And Training To Accelerate Medical Device Innovation In India

Andhra Pradesh MedTech Zone (AMTZ), India’s 1st Integrated Medical Devices Manufacturing Park which is being setup in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with the National Productivity Council (NPC) to contribute towards creating and sustaining the medical device eco-system in the country and support domestic manufacturing of medical devices. The MoU was signed by Dr.Jitendar Sharma, Director & CEO, AMTZ and Mrs. KalpanaAwasthi, Director General, NPC.

This MoU enables manufacturers at AMTZ with access to solutions towards accelerating productivity. The large integrated ecosystem being provided by AMTZ will be greatly complemented by the expertise at NPC to help medical device manufacturers enhance competitiveness, augment safety and reliability while ensuring better quality of products through training.NPC’s core focus of productivity as a means to improving triple bottom line of economic, environmental and social is aligned with AMTZ’s objectives of making healthcare affordable and accessible while placing India on the global map of high end medical equipment production.

AMTZ would include facilities such as electro-magnetic interference laboratory, 3D designing and printing for medical grade products,X-ray tube and radiation testing centre, gamma irradiation facility, rapid prototyping centre, metal molding and metal finishing centre, warehousing and regulator’s office.

NPC is national level organization to promote productivity culture in India. Promotional and catalytic in nature, NPC’s services have bearings on economic growth and quality of life.NPC’s thrust is on providing modern and high-quality productivity-related services to sectors not adequately addressed by others.

 

AMTZ signs MoU with IIT Bombay to boost innovation in medical device industry

The Andhra Pradesh MedTech Zone (AMTZ), which is setting up India’s first ultra-modern medical equipment manufacturing park in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with the Indian Institute of Technology, Bombay (IIT-B) for accelerating medical device innovation and commercialization within the country.

Signed between Dr Jitendar Sharma, CEO, AMTZ and Prof. Petety V Balaji, Dean, R&D, IIT Bombay, the MoU will enable manufacturers at AMTZ with access to laboratories, training programs and talent from IIT Bombay. New product development, research, government policy promotion will also receive a boost with this partnership between industry and academia.

Startups in the field of medical technology which are part of the IITB incubator programme will also benefit from the large integrated ecosystem being provided by AMTZ. This partnership will contribute positively towards the development of the overall medical technology ecosystem in the country.

AMTZ would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products,
sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

AMTZ which is India’s first Government funded medical device park is today serving as a one-stop- solution for not only reducing cost of manufacturing up to 40% and to simplify end-to- end operations but also reducing import dependency, which is presently around 75%.

AMTZ also has the distinction of becoming the second Indian park to become a full-time member of the International Association of Science Parks and Areas of Innovation (IASP). With AMTZ becoming a member of IASP, new business opportunities for companies and research organisations located within AMTZ and in Andhra Pradesh will be enhanced. This will also be a boost for development and growth of areas of innovation.

IASP is a membership-based global network for science parks and areas of innovation to drive growth, innovation and effectiveness. Headquartered at Málaga, Spain, IASP is headed by Josep Miquel Piqué as its President and Luis Sanz as the Director General.

Incorporated on 30 April 2016 and foundation stone laid on 19 August 2016, AMTZ is an enterprise under the Government of Andhra Pradesh, a 270 acre zone, dedicated for medical device manufacturing.

Dr. Jitendar Sharma, Director, AMTZ said, “AMTZ has become the first scientific park in the state and the second in the country to become a member of IASP which is a unique achievement of its kind.” This membership complements the approval of Kalam Institute of Health Technology, which AMTZ received recently

AMTZ, IIT-Bombay sign MoU for innovation in medical device industry

Andhra Pradesh MedTech Zone (AMTZ) has signed a Memorandum of Understanding (MoU) with Indian Institute of Technology-Bombay (IITB) to accelerate medical device innovation and commercialisation within the country.

“This partnership will contribute positively towards the development of the overall medical technology ecosystem in the country. New product development, research, government policy promotion will also receive a boost with this partnership between industry and academia,” AMTZ said.

As part of the MoU, IIT-Bombay would provide AMTZ with access to laboratories, training programs and talent. Startups in the field of medical technology which are part of the IITB incubator program will also benefit from the large integrated ecosystem being provided by AMTZ.

The MoU was signed by Jitendar Sharma, CEO, AMTZ and Petety V Balaji, Dean-R&D, IIT-Bombay.

AMTZ is setting up India’s first ultra-modern medical equipment manufacturing ecosystem in Visakhapatnam. The 270-acre business park  would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

AMTZ Signs MoU With IIT Bombay For Rapid Innovation In The Medical Device Industry

The Andhra Pradesh MedTech Zone (AMTZ), which is setting up India’s first ultra-modern medical equipment manufacturing ecosystem in Visakhapatnam, has signed a Memorandum of Understanding (MoU) with the Indian Institute of Technology, Bombay (IITB) for accelerating medical device innovation and commercialization within the country. The MoU was signed by Dr Jitendar Sharma, CEO, AMTZ and Prof. Petety V Balaji, Dean, R&D, IIT Bombay.

This MoU enables manufacturers at AMTZ with access to laboratories, training programs and talent from IIT Bombay. New product development, research, government policy promotion will also receive a boost with this partnership between industry and academia. Startups in the field of medical technology which are part of the IITB incubator program will also benefit from the large integrated ecosystem being provided by AMTZ.This partnership will contribute positively towards the development of the overall medical technology ecosystem in the country.

AMTZ would include facilities such as component testing centre, electro-magnetic interference laboratory, medical grade low vacuum molding, cabinet molding, injection molding centres, 3D designing and printing for medical grade products, sterilization and toxicity testing centre, radiation testing centre, gamma irradiation facility, rapid prototyping centre, warehousing and regulator’s office.

AMTZ becomes full time member of IASP to boost biz for cos and research bodies

Shardul Nautiyal, Mumbai
Wednesday, August 02, 2017, 08:00 Hrs  [IST]

Andhra Pradesh MedTech Zone (AMTZ) has become the second Indian park to become a full-time member of the International Association of Science Parks and Areas of Innovation (IASP). With AMTZ becoming a member of IASP, new business opportunities for companies and research organisations located within AMTZ and in Andhra Pradesh will be enhanced.

IASP is a membership-based global network for science parks and areas of innovation to drive growth, innovation and effectiveness.

AMTZ which is India’s first Government funded medical device park is today serving as a one-stop- solution for not only reducing cost of manufacturing up to 40% and to simplify end-to- end operations but also reducing import dependency, which is presently around 75%.

Incorporated on 30 April 2016 and foundation stone laid on 19 August 2016, AMTZ is an enterprise under the Government of Andhra Pradesh, a 270 acre zone, dedicated for medical device manufacturing.

This will also be a boost for development and growth of areas of innovation. Headquartered at Málaga, Spain, IASP is headed by Josep Miquel Piqué as its President and Luis Sanz as the Director General. Dr. Jitendar Sharma, Director, AMTZ said, “AMTZ has become the first scientific park in the state and the second in the country to become a member of IASP which is a unique achievement of its kind.”

This membership complements the approval of Kalam Institute of Health Technology, which AMTZ received recently.

AMTZ envisions to put India on the global map of high end medical equipment production and make health care products affordable and accessible not only for India but for world at large.

The creation of AMTZ is based on the premise that medical devices manufacturing requires certain high investment facilities which are too capital intensive for individual manufactures to invest upon. The zone with in-house high investment scientific facilities would help manufacturers reduce the cost of manufacturing by more than 40% to 50%. Currently, due to lack of such centrally located share-able facilities, either manufacturers do not undertake production of technologies requiring them or send their products abroad for process up-gradation and value addition.

While the zone would have all such facilities in-house to reduce manufacturing process costs, it would be in an area which is well connected with railways, roadways, waterways and airways with near presence of industrial corridors, and port to reduce logistical costs.

AMTZ now part of leading global network for science parks

Published on: August 01, 2017

Andhra Pradesh MedTech Zone (AMTZ) has become the second Indian company to become a full-time member of the International Association of Science Parks and Areas of Innovation (IASP), a leading global network for science parks and areas of innovation.

“AMTZ has become the first scientific park in the state and the second in the country to become a member of IASP which is a unique achievement of its kind,” said Dr Jitendar Sharma, Director and CEO, AMTZ in a statement.

IASP is a membership-based global network for science parks and areas of innovation that coordinates a very active network of professionals that manage areas of innovation and science and technology parks.

With AMTZ becoming a member of IASP, new business opportunities for companies and research organisations located within AMTZ and in Andhra Pradesh will be enhanced. This will also be a boost for development and growth of areas of innovation.

Headquartered at Málaga, Spain, IASP is headed by Josep Miquel Piqué as its President and Luis Sanz as the Director General.

This membership complements the approval of Kalam Institute of Health Technology, which AMTZ received recently.

Vizag set to be medical tech hub

The AMTZ, which will be the country’s first full-fledged medical devices manufacturing zone, will take off in October, this year.

Visakhapatnam: Vizag is set to become India’s medical technology capital, with the Andhra Med Tech Zone (AMTZ) and the Kalam Institute of Health Technology (KIHT) to come up in the city.

The AMTZ, which will be the country’s first full-fledged medical devices manufacturing zone, will take off in October, this year.

The zone will be bringing down healthcare cost in India significantly, as it would produce a range of medical devices, including the high-end ones such as CT scan, X-ray tubes, IV diagnostic devices, ECG, opthalmic equipment, heart and lung machines and ventilators.

“Today, India imports more than 75 per cent of the medical devices required.  In the high-end segment, the imports are to an extent of 95 per cent, touching Rs 24,000 crore annually.  Once they are manufactured locally, the cost of these devices will be lower, which will get reflected in healthcare costs,” Jitendar Sharma. CEO of AMTZ and health advisor to the AP government, told this newspaper.

The import dependency is about 85 per cent for products such as artificial dialysis apparatus & haemodialyser, defibrillator, lithotripsy equipment, ECHO, EEG, ECG, anaesthesia equipments, laparoscope and endoscope, 52 per cent for diagnostic imaging products like X-ray tubes, CT scan and MRI and 35 per cent for consumables like cardiac catheter, syringe, suture and dialysers. “We are even importing thermometers and X-ray films,” Mr Sharma pointed out.

The AMTZ, which will produce most of these devices, will have 240 units, 52 of which have already been booked by both foreign and Indian companies.

“Assuming that each of these units has a turnover of `50 crore, the total turnover would be Rs 12,000 crore, which is 50 per cent import substitution,” he explained.

To support the zone’s efforts, the new KIHT is also ready for inauguration. It will have a unique role in bringing out hundreds of prototypes gathering dust in medical research labs and health universities.

“We have identified at least 700 prototypes which can be made use of in the medical technology sector.  We will be auctioning these prototypes and pay back the money to the respective institutions, while the industry gets to keep the product,” Mr Sharma, who is also the executive director of the institute, said.

The first round of auction, involving 25 prototypes, will be held in three months through the Indian Medical Devices Manufacturers Association, the  executive director added.

AMTZ Joined Hand With Paytm To Enable Cashless Transaction For Entire Zone Of AMTZ

AMTZ partners with Paytm and further strengthen the vision of PM Sh. Narendra Modi

AMTZ the ultra-modern manufacturing hub for medical devices production added a feather in its cap by aiming to become the first cashless economic zone in the country. AMTZ on 8th July signed a Memorandum of Understanding (MoU) with One97 Communications Limitedwhich owns and operatesthe Paytm online platform and the Paytm app.The MoU with Paytm shall help enable cashless transactions for the entire zone of AMTZ including scientific tests and works, trading, payments for general and social services.

AMTZ which came into being on 19th Aug 2016 with the foundation laying ceremony has been on top of strategy and operations with several manufacturing units bee-lining into a basket of one of its scientific infrastructure. Paytm which has soared into public appeal with demonetization drive is country’s most population digital transaction portal. The MoU between AMTZ and Paytm is first of its kind partnership between an industrial hub and a transaction platform.

AMTZ holds training programme on quality certification for medical devices manufacturers

The Andhra Pradesh MedTech Zone (AMTZ), India’s first state-of-the-art medical devices manufacturing park in Visakhapatnam, organised a two-days industry training programme on quality certification with an aim to bring down the time and cost-run to obtain globally accepted quality certification for Indian manufacturers.

The training programme, held on 28th and 29th June and attended by medical devices manufacturers, medical professionals and other industry stakeholders, was organised in association with Quality Council of India (QCI), National Accreditation Board for Certification Bodies (NABCB) and Association of Indian Medical Device Industry (AIMED).

The programme mainly focused on helping medical device manufacturers understand EC (European Commission) regulations, CE (Conformité Européene) marking, Industry Indian Certification for Medical Devices (ICMED) certification and New Medical Device Rules, 2017.

The programme’s objective was to fill the regulatory space in quality certification for medical devices in the country. The key themes of the training sessions included EU regulatory, medical device definition and risk classification; CE Marking and New MDR; ICMED 9000 certification, which is ISO 9001 plus additional requirements; ICMED 13485, which is ISO 13485 plus additional requirements; and New Medical Device Rules, 2017.

Thanking QCI and NABCB for organising the event jointly “to exchange the knowledge share of regulations and application process for the medical device”, Dr Jitendar Kumar Sharma, CEO and Director, AMTZ, said: “With this event, we will aim to create a more progressive practice towards regulatory frame work in the medical device sector.”

Mrutunjay Jena, Joint Director, QCI, said, “QCI & AIMED in partnership with AMTZ is initiating a number of voluntary awareness Programs to facilitate industry and demonstrate compliance to the best global standards of which ICMED is one of them.”

AMTZ INKS PACT WITH COMMON SCIENTIFIC FACILITIES SERVICE PROVIDERS

AndhraPradesh MedTech Zone (AMTZ) on June 16, 2017 concretised formal agreements with the various scientific facilities which shall be within the country’s first Medical Technology Manufacturing Park spread over 270 acre. These facilities include: Centre for Electro-Magnetic Interference / Electro-Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for Biomaterials Testing, Centre for X-ray & CT Scan Tube Manufacturing, Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling, Centre for Gamma Irradiation and AMTZ Central Warehouse.

AMTZ shall be partnering with TÜV Rheinland India for the EMI/EMC & EST as well as the Biomaterials Testing Facilities; CURA Healthcare Pvt. Ltd. for the Centre for X-ray & CT Scan Tube Manufacturing; think3D for the Centre for 3D Designing, canning, Printing, Rapid Prototyping & Tooling; MICROTROL Sterilisation Services Pvt. Ltd. for the Gamma Irradiation Centre and Balmer Lawrie & Co. Limited for the Central Warehouse.

TÜV Rheinland India, a subsidiary of TÜV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting & Certification was represented by Mr. Thomas Fuhrmann, Managing Director, TÜV Rheinland India.CURA Healthcare Pvt. Ltd. was represented by its CEO, Mr. M. Balasubramaniam; Mr. Prudhvi Reddy, Co-founder, think3D; Mr. Vikram B. Kalia, Director, MICROTROL Sterilisation Services Pvt. Ltd. and Mr. K. Swaminathan, Director (Service Businesses), Balmer Lawrie & Co. Ltd. were present at the said event.While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high-level event.

Complementing the above-mentioned ecosystem, AMTZ has firmed up strategic tie-ups with Industry Associations including Association of Indian Medical Device Industry, Andhra Chamber of Commerce, GMDN Agency, India Angel Network, PHD Chamber of Commerce and Industry, Quality Council of India, UNITED ASIA and World Association for Small and Medium Enterprises; BIORx Venture Advisors Private Limited, HDFC Bank&NTrust Insurance Broking Services for Financial & Specialised Insurance services; Cerner Healthcare Solutions, Hibiscus Consulting, IZiel Healthcare, MarksMan Healthcare Solutions, Meshayu Consultants Private Limited, National Hub for Healthcare Instrumentation Development(NHHID), Operon Strategist and PC Process for Technology Transfer & Regulatory Consulting; monster.com for Human Resource facilitation and eLets Technomedia Pvt.Ltd., Medgate today Magazine and BMJ Noida as media partners. Along with this AMTZ has also launched bookings of office space for manufacturers.

Hyd-based Think3D to set up 3D printing facility at Andhra Pradesh Medtech Zone

The facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in PPP mode.

Think3D, a Hyderabad-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ).

AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D is a 3D printing solutions company which has it presence across 11 cities, over 50 brands and has 1000+ customers.

It provides services like 3D printing and prototype services where it build a full-fledged product with a 3D printer.

It supplies all kinds of 3D hardware like 3D printers, 3D scanners, and consumables with a dedicated support team to handle all post-sale requests.

It works in the medtech space where it provides various medical 3D printing solutions like pre-surgical aids, surgical guides & implants.

It also helps train students and conducts courses and workshops on 3D printing.

Think3D to set up facility at Andhra Medtech Zone

Think3D, a Hyderabad-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ).

AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D to set up facility in Andhra Pradesh

Hyderabad: Think3D, a city-based 3D printing solutions company, has bagged the contract to set up and operate a world-class 3D printing facility at the Andhra Pradesh Medtech Zone Limited (AMTZ). AMTZ is a prestigious medical devices manufacturing park being developed by the Andhra Pradesh government.

AMTZ signed an agreement for the construction, operation, management and maintenance of the 3D designing and printing facility, prototyping and rapid tooling at AMTZ on a PPP basis.

The scientific facility to be setup will be equipped with a range of 3D printing and other fabrication technologies, a maker lab for innovators and a 3D design facility for developing concepts to reality, the company said in a statement.

With an investment of $6 million and spread over an acre, the facility will be operational in a year’s time and will be the first of its kind to operate all services under one roof in the Public Private Partnership mode.

Think3D to open facility at Andhra Pradesh medical devices park

HYDERABAD: Three-dimensional printing solutions provider Think3D will be setting up a 3D printing facility in collaboration with Andhra Pradesh Medtech Zone (AMTZ) with an investment of $6 million, announced a top company executive.

The facility, to come up on an area of 20,000 sft, will offer prototyping and low volume manufacturing to medical devices companies in AMTZ.

Prudhvi Reddy, co-founder, Think3D said, “The facility will come up on an area of 17,000-20,000 sft in the first phase and then look at expanding in the remaining land of the one acre that has been allotted to us. While the infrastructure would be taken care of by the government, sourcing of devices and upkeep of the facility would be the responsibility of the company. We will be catering to over 400 companies including X-ray manufacturers at the park”.

The profit sharing ratio between AMTZ and Think3D is 70:30 which could change depending on the future investments made by each of the players, said a senior executive of Think3D seeking anonymity.

AMTZ, is an enterprise under the Andhra Pradesh government, a 270 Acre zone, dedicated for medical devices manufacturing and aims to reduce the cost of manufacturing by up to 40Rs and also reduce dependency on imports for medical devices, which is presently around 78Rs .

Co-founder of think3D tells us more about $6 million 3D Printing facility for medical devices

A $6 million state-of-the-art 3D printing facility is planned for the the city Visakhapatnam in India. Also known as Vizag, the city is the financial capital of the Indian state of Andhra Pradesh.

The additive manufacturing center will be built under an agreement between Andhra Pradesh MedTech Zone (AMTZ) and think3D. Raja Sekhar Upputuri is the co-founder of think3D who operate in 11 cities across the country. With over 1,000 customers think3D is India’s largest 3D printing platform.

AMTZ (AP Medical Tech Zone) is an SPV formed by the Indian government and the provincial government of Andhra Pradesh to promote medical device manufacturing in India and reduce dependence on imports for medical devices.

The 200 acre region where the $6 million 3D printing AMTZ facility will be set up photo via think3d and amtz
The 200 acre region where the $6 million 3D printing AMTZ facility will be set up photo via think3d and amtz

Addressing a $5.5 billion market

3D Printing Industry asked Raja Sekhar Upputuri a few questions about the plans.

“Currently the land development works are going on,” says the think3D co-founder. “Our facility and a few manufacturing companies should be open by October 2018. For full fledged activity in the park, it would easily take another 3-4 years.”

Vizag has the tenth largest economy in India. The planned 3D printing facility is intended to address the $5.5 billion Indian medical market, a figure that is expected to grow substantially in coming years. Currently approximately 75% of demand is met by imports. This means that the price of medical devices can fluctuate with currency movements, furthermore by importing the devices an opportunity to create jobs in the country is missed.

As previously reported by 3D Printing Industry, several countries are also establishing specialist medical 3D printing centers.

The global medical device market. Image via AMTZ
The global medical device market. Image via AMTZ

3D printing supports best-in-class manufacturing infrastructure

The $6 million facility is part of the central government’s “MAKE IN INDIA” project, a major national initiative designed to foster innovation and build a best-in-class manufacturing infrastructure.

The project provides an insight into the potential of 3D printing for Newly Industrialized Countries to leapfrog a development stage and move directly to advanced manufacturing. According to think3D,

Medical device manufacturing requires huge up-front investment in R&D, machinery and QC facilities. Some of these facilities have very little utilization rate but are required as part of the manufacturing process. Taking this into consideration, the government has decided to set-up these common facilities in partnership with private entities and offer these facilities to manufacturers within park on pay per use basis thus reducing the upfront investment from manufacturer cost drastically. 3D Printing & 3D design facility is chosen as one such common facility.
Prudhvi Raj, co-founder think3D signing contract with AMTZ for the $6 million medical 3D printing facility.
Prudhvi Raj, co-founder think3D signing contract with AMTZ for the $6 million medical 3D printing facility.

Come with an idea, leave with the finished prototype

Raja Sekhar Upputuri tells us that the facility will employ between 50 to 60 people. Work is underway to determine the 3D printing technology requirements, as he says,

We haven’t yet zeroed in on brands. As for types of machines, we definitely will have 1 metal 3D Printer, 2 – 3 SLS 3D Printers, a few SLA / DLP machines, many FDM machines, a few high end scanners like Artec, Faro. We also will have 1 or 2 CNC Machines, Vacuum casting machines as for some prototypes we need to employ traditional methods.
In additional to 3D printing, the 20,000 sq ft space will include state of-art reverse engineering facility and an expert 3D design facility. The intent is that, “manufacturers can come to the facility with just an idea and leave with the finished prototype.”

Raja Sekhar Upputuri also told us more about how 3D printing will be used in production of medical devices.

3D Printing will be used for prototype and batch production of few parts for medical devices. For example MRI, ECG, Ultrasound machines, different types of syringes and so on. TUV Rhineland is setting up a testing center in the facility to thoroughly test these devices before they are launched in the market.
The aforementioned TUV Rhineland deal is a partnership with Andhra Pradesh MedTech Zone (AMTZ). Under a public private partnership (PPP) – estimated at $13 million – the testing facilities will also be established in the region.

Dr. Jithendra Sharma, CEO AMTZ, explains, “We realized the need to have mega industrial partners in AMTZ. They will support manufacturers in producing quality product at an industrial cost-effective scale.”

The Andhra Pradesh MedTech Zone is India’s first manufacturing park specialising in medical technology, the zone will occupy 270 acres.

AMTZ, think3D announce $6M medical device 3D printing facility in India

Jun 19, 2017 | By Tess

Indian 3D printing platform think3D, a subsidiary of Singapore-based think3D Labs Pte Ltd., has announced it will be establishing a $6 million 3D printing facility in Vizag, Andhra Pradesh, India. The center is being realized in collaboration with the Andhra Pradesh MedTech Zone (AMTZ), a special-purpose entity formed by the Indian government and the Andhra Pradesh provincial government with the goal of advancing medical device manufacturing in the country.

The $6 million facility is expected to enable India’s medical device market (worth $5.5 billion and on the rise) to become more independent. Currently, nearly 75% of the market is made up of imported devices, a reality which hinders the country’s economy and employment growth.

Part of the effort to increase medical device manufacturing in India is coming from MAKE IN INDIA, a government-led initiative aimed at promoting and expanding Indian design and manufacturing on the whole. Together with the government of Andhra Pradesh, MAKE IN INDIA has launched India’s first medical technology manufacturing park and is encouraging local manufacturers to use its facilities with the support of subsidies.

At the park, one facility will be dedicated to 3D printing and 3D design. There, manufacturers in India will be able to benefit from state-of-the-art additive manufacturing equipment on a pay-per-use basis. This method will allow businesses to bypass large investments in equipment and their own manufacturing facilities without having to sacrifice high-end technologies.

“We realized the need to have mega industrial partners in AMTZ,” says Dr. Jithendra Sharma, CEO of AMTZ. “They will support manufacturers in producing quality product at an industrial cost-effective scale.”

Visit to the AMTZ site

think3D was chosen to help AMTZ set up and manage the 3D Printing & 3D Design facility after submitting a tender. Through the tender agreement, AMTZ will provide think3D with equipment through the facility on lease, while think3D will use its own expenses to manage the facility, offering services to customers at a subsidized rate (or at market rate for non-park customers).

The facility itself will span 20,000 square feet and will feature a number of metal, SLS, SLA, and bio 3D printers, as well as a reverse engineering facility and 3D design tools. “We are very excited to be part of AMTZ facility and contribute to the MAKE IN INDIA initiative,” said Raja Sekhar Upputuri, co-founder of think3D. “A state-of-art 3D printing & 3D designing facility helps manufacturers bring innovative products into the market at a much faster pace. We look forward to see some great medical devices coming out of this park in years to come.”

“think3D got selected in the tendering process by winning both technical and financial bids,” added Nitin Bharadwaj, Vice President of Operations at AMTZ Ltd. “We believe think3D is a perfect partner for us to manage the 3D facility in the park. We were looking for one entity having expertise in 3D design, 3D scanning, and 3D printing fields and think3D fits the bill perfectly. We have seen various case studies they executed and are very excited about the value they bring to the park.”

According to market intelligence solutions firm 6Wresearch, India’s 3D printing market is expected to reach $62 million by the year 2022.

think3D Tapped by Provincial Indian Government to Open 3D Printing and Design Facility in Medical Device Park

India-based think3D, the largest desktop 3D printing platform in the country, has been around since 2014. Since it opened its doors, the organization, which is a subsidiary of Singapore-based think3D Labs Pte Ltd, has presented a 3D printing art exhibit at an international school, supplied 3D printed models for an initiative with India’s Devnar Foundation for the Blind, helped several engineering students test out their newly developed metal 3D printer, and last year unveiled its new mobile app for Android. Recently, think3D won a government tender to set up a new 3D printing facility in India.

Render via AMTZ showing advanced manufacturing facilities; may depict the UK’s AMP
The $6 million state-of-the-art facility in Vizag will be developed in partnership with the provincial Indian government of Andhra Pradesh, which is the eighth largest state in India. The facility will be part of a new medical devices park, the Andhra Pradesh Medical Tech Zone (AMTZ), which is an SPV formed by the Andhra Pradesh government and the Indian government to reduce the country’s dependence on imported medical devices and promote this type of manufacturing within India. The medical device manufacturing zone is roughly 270 acres.
“We realized the need to have mega industrial partners in AMTZ,” said Dr. Jithendra Sharma, the CEO of AMTZ. “They will support manufacturers in producing quality product at an industrial cost-effective scale.”
The medical device market in India is worth $5.5 billion, and huge growth is expected in the next several years. However, nearly 75% of the market is made up of imported medical devices, which means a monetary and employment loss for the country. The AMTZ park was founded to encourage medical device manufacturers to set up shop in India, as part of the central government’s Make In India initiative, which was launched two years ago as a means of transforming the country into a global manufacturing and design hub.

Prudhvi Raj, co-founder of think3D, signing contract with AMTZ
A substantial up-front investment is required for medical device manufacturing, in order to pay for research and development efforts, quality control, and quality machinery facilities. Some facilities, while a required part of the manufacturing process, do not have much of a utilization rate, which is why the government in India made the decision to partner up with private entities to break ground on common facilities, and allow manufacturers in the AMZT park the option to use the 3D printing manufacturing and design facility on a pay-per-use basis, which lowers the manufacturer’s up-front cost significantly.

200-acre region where AMTZ facility will be set up
A tender was floated to choose a private entity to work with AMTZ to set up and manage the 3D printing and design facility at the park, and after a long technical and financial evaluation, think3D was chosen.
“As per government rules, we floated a tender for an entity to set-up and manage day-to-day operations at the facility. think3D got selected in the tendering process by winning both technical and financial bids,” explained Nitin Bharadwaj. Vice President, Operations, AMTZ Ltd. “We believe think3D is a perfect partner for us to manage the 3D facility in the park. We were looking for one entity having expertise in 3D Design, 3D Scanning & 3D Printing fields and think3D fits the bill perfectly. We have seen various case studies they executed and are very excited about the value they bring to the park.”
think3D will set up and manage, as part of its agreement with AMTZ, a 20,000-square-foot rapid prototyping facility, an expert 3D design facility, and a reverse engineering facility; the rapid prototyping facility will house various high-quality metal 3D printers for any SLS, SLA, and bioprinting needs. AMTZ will purchase the 3D printers, and lease both the facility and the machinery to think3D, which will manage the whole operation at its own expense while offering 3D printing customers at the park a subsidized pay-per-use rate; a market rate will be available for any entities outside of the park.

“We are very excited to be part of AMTZ facility and contribute to the MAKE IN INDIA initiative,” said Raja Sekhar Upputuri, think3D Co-Founder. “A state-of-art 3D printing & 3D designing facility helps manufacturers bring innovative products into the market at a much faster pace. We look forward to see some great medical devices coming out of this park in years to come.”
When government and 3D printing mix, things can definitely take a positive turn in the manufacturing and education sectors – just look at everything that’s been accomplished since the Dubai 3D Printing Strategy was established. But this isn’t always the case, so it will be interesting to see what comes of the AMTZ and think3D partnership. Discuss in the think3D forum at 3DPB.com.

TUV Rheinland partners with AP MedTech Zone to set up testing unit investing Rs 85 crore

Our Bureau, Bengaluru
Monday, June 19, 2017, 15:00 Hrs [IST]
TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a global leader in Testing, Training, Inspection, Consulting & Certification has partnered with Andhra Pradesh MedTech Zone (AMTZ), the country’s first Medical Technology Manufacturing Park at Visakapatnam. The company will set up a test facility here investing around Rs. 85crore.

As per the terms of the partnership, TUV Rheinland India has been awarded a contract to set up and operate Electro-Magnetic Interference (EMI/EMC) including Anechoic Chambers, Biomaterial, Reliability & Electrical Safety Testing Facilities on Public Private Partnership Mode within AMTZ at an estimated investment of about Rs 85 crore over 4-5 years to support AMTZ’s objective to reduce medical device imports and production cost, partner with industry to deliver the quality medical devices to local market and eventually increase the export of world class medical devices to the international market.

The contract was inked by Thomas Fuhrmann, Managing Director,TUV Rheinland India and Dr. Jitendar Kumar Sharma, Director & CEO of AMTZ. While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high level event.

AMTZ will house modern 250-300 independent manufacturing units,each over a built-in ready to use area at a very cost effective long-term lease. In addition the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories, which would help manufacturers significantly reduce the cost manufacturing thereby creating world class diagnosis with quality products accessible to the common man at affordable prices.

“We are honoured that AMTZ has selected TUV Rheinland as its partner to establish testing laboratories within the zone and assist in its ‘Make In India’ drive”, said Thomas Fuhrmann, Managing Director, TUV Rheinland India.

“This is a result of our rich expertise and experience in supporting local and multinational medical device manufacturers in their verification & validation, equipment testing and certification activities,” he added.
“As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the Medical device manufacturers within the zone. Also as these world class test facilities are within the zone, Medical device manufacturers can use the labs that are available in next door. This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, Vice President Products, TUV Rheinland India.

TUV Rheinland along with other scientific labs within the Zone can act as one-stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published medical devices rules 2017 which will come into force from 1st Jan 2018, he added.

TUV Rheinland, State ink pact

Medical devices testing lab to be set up in MedTech Zone

The Medical Devices Park that is coming up in the district will have about 250-300 medical devices manufacturing units, according to Jitendra Kumar Sharma, CEO of Andhra Pradesh MedTech Zone (AMTZ).

He was speaking at the signing of an MoU between the State government and TUV Rheinland (India) Private Limited, an Indian subsidiary of the German firm, here on Friday.

“There is immense potential for import substitution, and at a later stage for exports also, of medical devices in India as 80% of the devices are being imported at present, said Thomas Fuhrmann, CEO and MD of TUV Rheinland (India) Private Limited. TUV will be setting up a medical devices testing lab in the Medical Devices Park, which is coming up in an extent of 270 acres. Mr. Fuhrmann further said his company had been awarded the contract to set up and operate the laboratory with facilities for testing electro-magnetic interference (EMI/EMC), anechoic chambers, bio-material reliability and electrical safety. “The State government would provide the land, two acres or so, in the park and we have to invest roughly about ₹100 crore on the lab,” he said.

He also lauded the efforts of the State government in setting up the park, which would give a great boost to the sector in the State and in the country.

Advantages

Vice-president of the company Kalyan Verma said: “Availability of world-class testing facilities within the Medical Devices Park will make it easier for the manufacturers to improve quality. It will reduce logistics cost and the manufacturers can get their products tested within the park in accordance with the new Medical Devices Rules, 2017, coming into force from January 1, 2018.” The testing lab would be ready by next year.

Andhra Pradesh ties up with TUV Rheinland to test medical devices

HYDERABAD: German technical services provider TUV Rheinland’s Indian subsidiary has partnered with Andhra Pradesh MedTech Zone (AMTZ) to create an infrastructure for Electro-Magnetic Interference (EMI/EMC) at an investment of Rs 85 crore over four to five years.

The public-private partnership is aimed at reducing the medical devices imports and production cost and to help deliver quality medical devices to local market.

Thomas Fuhrmann, managing director, TUV Rheinland India, said, “We have been selected by AMTZ for operation, management and maintenance of Electro-Magnetic Interference (EMI/EMC), electrical safety and biomaterial testing laboratories. These laboratories on a high level will have state-of-the facilities for testing of electrical and electronic products”.
The contract was signed on Friday by Thomas Fuhrmann and.Jitendar Kumar Sharma, director and chief executive officer (CEO), AMTZ.

“As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the medical device manufacturers within the zone. Also, as these world class test facilities are within the zone, manufacturers can use the labs that are available. This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, vice-president, products, TUV Rheinland India.

He added that TUV Rheinland along with other scientific labs within the zone can act as one stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published medical devices rules 2017 which will come into force from January 1, 2018.

Spread over an area of 270 acres, AMTZ will house 250-300 modern independent manufacturing units as it seeks to reduce the cost of manufacturing medical devices. With a market size of close to $4 Billion, 78% of medical devices in India are imported from other countries.

TUV Rheinland India to set up testing facilities in AMTZ

TUV Rheinland India, a global leader in testing, training, inspection, consulting and certification of medical devices, has joined hands with Andhra Pradesh MedTech Zone (AMTZ) to set up testing facilities in the country’s first medical technology manufacturing park on the public private partnership mode.

The subsidiary of TUV Rheinland Group, Germany, will invest about Rs 85 crores over a period of four-five years in the recently established medtech park at Visakhapatnam to help it achieve its objective of reducing medical device imports, production cost and partner with industry to deliver quality medical devices to local market, and eventually increase the export of world class medical devices to the international market.

The contract was signed on Friday by Thomas Fuhrmann, Managing Director of TUV Rheinland India and Dr Jitendar Kumar Sharma, Director and CEO of AMTZ. While agreement signing kick-starts a series of technical works, a formal exchange of this agreement is shortly scheduled at a high-level event.

“We are honoured that AMTZ has selected TUV Rheinland as its partner to establish testing laboratories within the zone and assist in it’s ‘Make In India’ drive”, said Fuhrmann.

“TUV Rheinland India has been selected by AMTZ for operation, management and maintenance of electro-magnetic interference (EMI/EMC), electrical safety and biomaterial testing laboratories. These laboratories on a high level will have state-of-the facilities for testing of electrical and electronic products including medical devices for EMI/EMC, electrical safety and biomaterial,” he added.

As AMTZ is investing on infrastructure and test equipment, it is evident that TUV Rheinland will have a very special price for the medical device manufacturers within the zone.

Also, as these world class test facilities are within the zone, medical device manufacturers can use the labs that are available in next door.

“This would reduce the overall product developmental lifecycle, logistics charges and turnaround time to market,” said Kalyan Varma, Vice President Products, TUV Rheinland India.

“TUV Rheinland along with other scientific labs within the zone can act as one-stop solution for the manufacturers within the zone to have their products tested and certified as per the newly published Medical Devices Rules 2017 which will come into force from 1st January 2018,” Varma added.

TUV Rheinland is the only certification body in India that boasts of an accredited welding institute offering welding courses to the industry in order to enhance the technical skills of its employees. The company has ambitious plans for setting up of laboratories in other parts of India as well in the near future.

AMTZ partners with GMDN Agency for identification of medical devices

Attracting attention of medical device fraternity across the world, the Andhra Pradesh MedTech Zone (AMTZ) recently joined the Global Medical Device Nomenclature (GMDN) Agency as partners.

The GMDN Agency is responsible for the Global Medical Device Nomenclature used for identification of medical devices. Formed in 1991, medical device experts from around the world (regulators, healthcare providers and manufacturers) have compiled the GMDN to facilitate taxonomy on medical devices.

GMDN is a list of generic names used to identify all medical device products including those used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.

A standardized and unambiguous system for naming and coding medical devices is critical in an environment increasingly dependent on electronic data records for sharing and storing patient information. GMDN is recommended by the International Medical Device Regulators Forum (IMDRF) and is now used by over 70 national
medical device regulators to support their activity.

With AMTZ as a Consulting Organisation to GMDN, it will be a great value-addition to all the manufacturers at AMTZ. GMDN association with AMTZ will come as an enabler of export and global market expansion potential.

In order to facilitate regulation of medical device with classification system as stipulated in medical device rules, 2017 among other aspects like sale and distribution, import and labeling of medical devices, Union Health Ministry has permitted AMTZ to host a dedicated help desk for understanding and smooth implementation of Medical Device Rules, 2017.

The help desk would also facilitate information on following changes of medical devices rules to manufacturers like licensing authorities and functions of notified body, manufacture of medical devices for sale and distribution, import and labeling of medical devices, clinical investigation of medical device and clinical performance evaluation of IVD’s, import or manufacture medical device which does not have predicative device, duties of medical device officer, medical device testing officer and notified body, registration of laboratory for carrying out test for evaluation.

Taking forward its mandate of Make in India, Government of Andhra Pradesh last year established country’s first medical technology manufacturing park, AMTZ in Vishakhapatnam. N Chandrababu Naidu, chief minister of Andhra Pradesh laid the foundation stone of AMTZ.

Since then, AMTZ has received good response in terms of commencing of booking of plots and its active participation at Indian Medical Device Conference – 2017, one of the largest events for the Indian pharmaceutical market.

The Union health ministry notified the Medical Devices Rules, 2017 which will come into force from January 1, 2018.

These Rules will be applicable to substances used for in vitro diagnosis and surgical dressings, surgical bandages, surgical staples, surgical sutures, ligatures, blood and blood component collection bag with or without anticoagulant covered under sub-clause (i); substances including mechanical contraceptives (condoms, intrauterine devices, tubal rings), disinfectants and insecticides notified under sub-clause (ii); and devices notified from time to time under sub-clause (iv), of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940).

AMTZ joins hands with GMDN Agency

Providing the much required boost to manufacturers of medical devices, Andhra Pradesh MedTech Zone (AMTZ), India’s first state-of-the-art medical devices manufacturing park, recently joined hands with GMDN Agency as a partner.

The move, which attracted attention of medical device fraternity across the world, is aimed at providing the much required boost to manufacturers of medical devices by promoting exports and facilitating global expansion.

GMDN, compiled by medical device experts from around the world, came into existence in 1991 to enable taxonomy on medical devices.

GMDN is a compilation of generic names to identify medical devices used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.

AMTZ will collaborate with GMDN as a consulting organisation, bringing value-addition to the makers of medical devices in the 270-acre business park located in Visakhapatnam, which is dedicated to medical device manufacturing.

Taxonomy of medical devices assumes significance in view of the increasing importance of electronic data records for sharing and storing patient information.

The International Medical Device Regulators Forum (IMDRF), which was established in 2011 with an aim to harmonise medical device regulatory activities across the globe, recommends GMDN to regulators and is being used by over 70 national medical device regulators to support their activity.